Amedeo Smart

Free Medical Literature Service

 

Amedeo

COVID-19
  Free Subscription

Articles published in
Clin Infect Dis
    April 2025
  1. MESSCHENDORP AL, Zaeck LM, Bouwmans P, van den Broek DAJ, et al
    Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial.
    Clin Infect Dis. 2025 Apr 15:ciaf107. doi: 10.1093.
    >> Share

  2. IOANNOU GN, Berry K, Rajeevan N, Li Y, et al
    Target Trial Emulation of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus No Infection and Risk of Post-Coronavirus Disease 2019 Conditions in the Omicron Variant Versus Prior Eras.
    Clin Infect Dis. 2025 Apr 10:ciaf087. doi: 10.1093.
    >> Share

  3. ADAMS K, Garg S, Tartof SY, Irving SA, et al
    Patterns in prescribing and dispensing of influenza antivirals among adults with influenza presenting to urgent care and emergency department settings, VISION Network, 2023-2024.
    Clin Infect Dis. 2025 Apr 4:ciaf178. doi: 10.1093.
    >> Share

  4. DORAIVELU K, Williams S, Hazell M, Smith S, et al
    The dynamic impact of community social vulnerability on COVID-19 outcomes: A census tract-level analysis of Fulton County, GA.
    Clin Infect Dis. 2025 Apr 3:ciaf177. doi: 10.1093.
    >> Share

    March 2025
  5. ALLAN-BLITZ LT, Klausner JD
    Shifting the Focus in Acute SARS-CoV-2 Management to Include Prevention of Long-COVID.
    Clin Infect Dis. 2025 Mar 26:ciaf158. doi: 10.1093.
    >> Share

  6. COX SN, Roychoudhury P, Frivold C, Acker Z, et al
    Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023.
    Clin Infect Dis. 2025 Mar 14:ciaf048. doi: 10.1093.
    >> Share

  7. KELLY JD, Hoggatt KJ, Lo NC, Leonard S, et al
    Annual variant-targeted vaccination to prevent severe COVID-19 disease in cohorts with vaccine-derived and hybrid immunity.
    Clin Infect Dis. 2025 Mar 14:ciaf124. doi: 10.1093.
    >> Share

  8. ROCKSTROH JK, Paredes R, Cahn P, Molina JM, et al
    Doravirine/islatravir (100/0.75 mg) once-daily compared to bictegravir/emtricitabine/tenofovir alafenamide as initial HIV-1 treatment: 48-week results from a phase 3, randomized, controlled, double-blind, non-inferiority trial.
    Clin Infect Dis. 2025 Mar 13:ciaf077. doi: 10.1093.
    >> Share

  9. BARTOLETTI M, Mozaffari E, Amin AN, Doi Y, et al
    A systematic review and meta-analysis of the effectiveness of remdesivir to treat SARS-CoV-2 infection in hospitalized patients: have the guidelines evolved with the evidence?
    Clin Infect Dis. 2025 Mar 11:ciaf111. doi: 10.1093.
    >> Share

    February 2025
  10. SWARTWOOD NA, Cohen T, Marks SM, Hill AN, et al
    Effects of the COVID-19 pandemic on TB outcomes in the United States: a Bayesian analysis.
    Clin Infect Dis. 2025 Feb 27:ciaf092. doi: 10.1093.
    >> Share

  11. BULLOCK A, Dalton AF, Stockwell MS, McLaren SH, et al
    Ongoing Symptoms After Acute SARS-CoV-2 or Influenza Infection in a Case-Ascertained Household Transmission Study: 7 US Sites, 2021-2023.
    Clin Infect Dis. 2025 Feb 26:ciaf026. doi: 10.1093.
    >> Share

  12. SIM BZ, Wolfe CR
    Antiviral Trials-Navigating the Shifting Sands of a Pandemic.
    Clin Infect Dis. 2025 Feb 17:ciaf031. doi: 10.1093.
    >> Share

  13. LUETKEMEYER AF, Chew KW, Lacey S, Hughes MD, et al
    Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial.
    Clin Infect Dis. 2025 Feb 17:ciaf029. doi: 10.1093.
    >> Share

  14. MANDEL H, Yoo YJ, Allen AJ, Abedian S, et al
    Long-COVID incidence proportion in adults and children between 2020 and 2024.
    Clin Infect Dis. 2025 Feb 5:ciaf046. doi: 10.1093.
    >> Share

  15. REGAN AK, Rowe SL, Sullivan SG, Coates MM, et al
    Coronavirus Disease 2019 Antiviral Medication Use Among Pregnant and Recently Pregnant US Outpatients.
    Clin Infect Dis. 2025 Feb 5:ciae580. doi: 10.1093.
    >> Share

  16. SMITH EA, Javier GM, Multani A, Beaird OE, et al
    Anti-SARS-CoV-2 IgG Antibody Titers in Cotemporary lots of Intravenous Immune Globulin and Fresh Frozen Plasma Compared to COVID Convalescent Plasma.
    Clin Infect Dis. 2025 Feb 3:ciaf045. doi: 10.1093.
    >> Share

    January 2025
  17. XIANG W, Steinbeis F, Dhindsa K, Kurth F, et al
    Predicting the risk of intensive care unit admission in patients with COVID-19 presenting in the emergency room: Development and evaluation of the CROSS score.
    Clin Infect Dis. 2025 Jan 10:ciaf006. doi: 10.1093.
    >> Share

    December 2024
  18. KONKLE SL, Magleby R, Bonacci RA, Segaloff HE, et al
    Post-COVID Condition Risk Factors and Symptom Clusters and Associations with Return to Pre-COVID Health-Results from a 2021 Multi-State Survey.
    Clin Infect Dis. 2024 Dec 20:ciae632. doi: 10.1093.
    >> Share

  19. HERBERT C, Antar AAR, Broach J, Wright C, et al
    Relationship Between Acute Severe Acute Respiratory Syndrome Coronavirus 2 Viral Clearance and Long Coronavirus 2019 (Long COVID) Symptoms: A Cohort Study.
    Clin Infect Dis. 2024 Dec 18:ciae539. doi: 10.1093.
    >> Share

  20. ANTOON JW, Amarin JZ, Hamdan O, Stopczynski T, et al
    Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study.
    Clin Infect Dis. 2024 Dec 17:ciae573. doi: 10.1093.
    >> Share

  21. RAWSON JMO, Donaldson EF, O'Rear JJ, Harrington PR, et al
    Independent FDA Analyses of Nirmatrelvir/Ritonavir Resistance in the Phase 2/3 Trials EPIC-HR and EPIC-SR.
    Clin Infect Dis. 2024 Dec 17:ciae615. doi: 10.1093.
    >> Share

  22. SHITTU I, Silva D, Oguzie JU, Marushchak LV, et al
    A One Health Investigation into H5N1 Avian Influenza Virus Epizootics on Two Dairy Farms.
    Clin Infect Dis. 2024 Dec 10:ciae576. doi: 10.1093.
    >> Share

  23. WEE LE, Lim JT, Goel M, Malek MIA, et al
    Bivalent boosters and risk of post-acute sequelae following vaccine-breakthrough SARS-CoV-2 Omicron infection: a cohort study.
    Clin Infect Dis. 2024 Dec 5:ciae598. doi: 10.1093.
    >> Share

  24. PINANA JL, Carbonell-Asins JA, Gomez D, Montoro J, et al
    Community-Acquired Respiratory Virus Infections: A Threat to Long-Term survivors after Allogeneic Stem Cell Transplant?
    Clin Infect Dis. 2024 Dec 5:ciae602. doi: 10.1093.
    >> Share

    November 2024
  25. LEWIS NM, Harker EJ, Grant LB, Zhu Y, et al
    Benefit of early oseltamivir therapy for adults hospitalized with influenza A: an observational study.
    Clin Infect Dis. 2024 Nov 28:ciae584. doi: 10.1093.
    >> Share

  26. FAUCI AS, Folkers GK
    HIV/AIDS and COVID-19: Shared Lessons from Two Pandemics.
    Clin Infect Dis. 2024 Nov 27:ciae585. doi: 10.1093.
    >> Share

  27. TOWNSEND JP, Hassler HB, Dornburg A
    Optimal Annual COVID-19 Vaccine Boosting Dates Following Previous Booster Vaccination or Breakthrough Infection.
    Clin Infect Dis. 2024 Nov 26:ciae559. doi: 10.1093.
    >> Share

  28. BROWN KA, Ulloa AC, Buchan SA, Daneman N, et al
    Association between use of a voluntary isolation centre and reduced household SARS-CoV-2 transmission: A matched cohort study from Toronto, Canada.
    Clin Infect Dis. 2024 Nov 20:ciae526. doi: 10.1093.
    >> Share


  29. Correction to: Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination.
    Clin Infect Dis. 2024 Nov 15:ciae506. doi: 10.1093.
    >> Share

  30. GRANT R, de Kraker MEA, Buetti N, Jackson H, et al
    In-hospital outcomes of healthcare-associated COVID-19 (Omicron) versus healthcare-associated influenza: a retrospective, nationwide cohort study in Switzerland.
    Clin Infect Dis. 2024 Nov 13:ciae558. doi: 10.1093.
    >> Share

  31. HAMMOND J, Leister-Tebbe H, Gardner A, Abreu P, et al
    Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-Risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A phase 3 randomized trial.
    Clin Infect Dis. 2024 Nov 11:ciae551. doi: 10.1093.
    >> Share

  32. MORTEZAVI M, Sloan A, Singh RSP, Chen LF, et al
    Virologic Response and Safety of Ibuzatrelvir, a Novel SARS-CoV-2 Antiviral, in Adults With COVID-19.
    Clin Infect Dis. 2024 Nov 2:ciae529. doi: 10.1093.
    >> Share

    October 2024
  33. BHIMRAJ A, Falck-Ytter Y, Kim AY, Li JZ, et al
    2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis.
    Clin Infect Dis. 2024 Oct 29:ciae435. doi: 10.1093.
    >> Share

  34. KALIL AC, Chandak A, Moore LSP, Ahuja N, et al
    Public Health Benefits of Applying Evidence-Based Best Practices in Managing Patients Hospitalized for COVID-19.
    Clin Infect Dis. 2024 Oct 25:ciae517. doi: 10.1093.
    >> Share

  35. WHITE EB, Grant L, Mak J, Olsho L, et al
    Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022-2023: A Prospective Cohort Study.
    Clin Infect Dis. 2024 Oct 24:ciae491. doi: 10.1093.
    >> Share

  36. KURITZKES DR
    Remdesivir for Patients Hospitalized with COVID-19: Evidence of Effectiveness from Cohort Studies in the Omicron Era.
    Clin Infect Dis. 2024 Oct 24:ciae515. doi: 10.1093.
    >> Share

  37. MOZAFFARI E, Chandak A, Berry M, Sax PE, et al
    Management of vulnerable patients hospitalized for COVID-19 with remdesivir: a retrospective comparative effectiveness study of mortality in US hospitals.
    Clin Infect Dis. 2024 Oct 19:ciae512. doi: 10.1093.
    >> Share

  38. HURWITZ KE, Rathnayaka N, Hendrickson K, Brookhart MA, et al
    Propensity score methods for confounding control in observational studies of therapeutics for COVID-19 infection.
    Clin Infect Dis. 2024 Oct 16:ciae516. doi: 10.1093.
    >> Share

  39. MOZAFFARI E, Chandak A, Gottlieb RL, Kalil AC, et al
    Remdesivir Effectiveness in Reducing the Risk of 30-day Readmission in Vulnerable Patients Hospitalized for COVID-19: A Retrospective US Cohort Study Using Propensity Scores.
    Clin Infect Dis. 2024 Oct 15:ciae511. doi: 10.1093.
    >> Share

  40. MOZAFFARI E, Chandak A, Gottlieb RL, Chima-Melton C, et al
    Remdesivir-associated survival outcomes among immunocompromised patients hospitalized for COVID-19: real-world evidence from the Omicron dominant era.
    Clin Infect Dis. 2024 Oct 15:ciae510. doi: 10.1093.
    >> Share

  41. MUNRO AP, House T
    Cycles of susceptibility: Immunity debt explains altered infectious disease dynamics post -pandemic.
    Clin Infect Dis. 2024 Oct 11:ciae493. doi: 10.1093.
    >> Share

    September 2024
  42. TRAN KC, Asfar P, Cheng M, Demiselle J, et al
    Effects of Losartan on Patients Hospitalized for Acute COVID-19: A Randomized Controlled Trial.
    Clin Infect Dis. 2024;79:615-625.
    >> Share

  43. FONG Y, Dang L, Zhang B, Fintzi J, et al
    Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
    Clin Infect Dis. 2024 Sep 26:ciae465. doi: 10.1093.
    >> Share


  44. Correction to: Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time series Analysis of 2017-2021 Data.
    Clin Infect Dis. 2024 Sep 25:ciae455. doi: 10.1093.
    >> Share

  45. LEE TC
    Remdesivir for COVID-19 in 2024 and beyond: checking the expiry date of the milk carton.
    Clin Infect Dis. 2024 Sep 20:ciae478. doi: 10.1093.
    >> Share

  46. MOZAFFARI E, Chandak A, Gottlieb RL, Chima-Melton C, et al
    Lower mortality risk associated with remdesivir + dexamethasone versus dexamethasone alone for the treatment of patients hospitalized for COVID-19.
    Clin Infect Dis. 2024 Sep 20:ciae477. doi: 10.1093.
    >> Share

  47. JENSEN TO, Harper K, Gupta S, Liu ST, et al
    Impact of baseline SARS-CoV-2 load in plasma and upper airways on the incidence of acute extrapulmonary complications of COVID-19: a multicentric, prospective, cohort study.
    Clin Infect Dis. 2024 Sep 13:ciae469. doi: 10.1093.
    >> Share

    August 2024
  48. LANDETE P, Caliman-Sturdza OA, Lopez-Martin JA, Preotescu L, et al
    A phase III randomized controlled trial of plitidepsin, a marine derived compound, in hospitalized adults with moderate COVID-19.
    Clin Infect Dis. 2024 Aug 26:ciae227. doi: 10.1093.
    >> Share

  49. RINCON-GUEVARA O, Wallace B, Kompaniyets L, Barrett CE, et al
    Association between SARS-CoV-2 infection during pregnancy and gestational diabetes: a claims-based cohort study.
    Clin Infect Dis. 2024 Aug 19:ciae416. doi: 10.1093.
    >> Share

  50. BERTHAUD V, Creech CB, Rostad CA, Carr Q, et al
    Safety and Immunogenicity of an mRNA-1273 Booster in Children.
    Clin Infect Dis. 2024 Aug 19:ciae420. doi: 10.1093.
    >> Share

  51. GRISEL B, Kaur K, Swain S, Gorenshtein L, et al
    The Ethical Obligation to Treat Infectious Patients: A Systematic Review of Reasons.
    Clin Infect Dis. 2024;79:339-347.
    >> Share

  52. WOOTEN D
    The Arrivals Gate at Heathrow Airport.
    Clin Infect Dis. 2024;79:289-291.
    >> Share

  53. TRIBBLE AC, Moorthy GS, Vartanian RJ, Smith MJ, et al
    Pediatric Antimicrobial Stewardship Programs Reduce Antibiotic Use at Combined Adult-Pediatric Hospitals.
    Clin Infect Dis. 2024;79:321-324.
    >> Share

  54. CASADEVALL A, Focosi D, Pirofski LA, Shoham S, et al
    Single monoclonal antibodies should not be used for COVID-19 therapy: a call for antiviral stewardship.
    Clin Infect Dis. 2024 Aug 8:ciae408. doi: 10.1093.
    >> Share

  55. MA KC, Surie D, Lauring AS, Martin ET, et al
    Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024.
    Clin Infect Dis. 2024 Aug 6:ciae405. doi: 10.1093.
    >> Share

    July 2024
  56. VILORIA WINNETT A, Stenzel T, Ismagilov RF
    Validating combination throat-nasal swabs for COVID-19 tests would improve early detection, especially for the most vulnerable.
    Clin Infect Dis. 2024 Jul 23:ciae381. doi: 10.1093.
    >> Share

  57. FAUST JS, Meyerowitz-Katz G
    Is Paxlovid Still Worth It?
    Clin Infect Dis. 2024;79:111-114.
    >> Share

  58. GREEN E, Marcelin JR
    Robust Performance Metrics for Assessing Equitable Clinical Trial Participant Enrollment: Can We Get There?
    Clin Infect Dis. 2024;79:148-150.
    >> Share

  59. CHEYNE A, Muchamore I, Tulunay H, Rojek A, et al
    Community Involvement in an Outbreak-One Year on for Mpox.
    Clin Infect Dis. 2024;79:278-280.
    >> Share

  60. CHERABIE JN, Hazra A
    Community-Informed Approach Remains Critical to Our Mpox Response.
    Clin Infect Dis. 2024;79:280-281.
    >> Share

  61. JILG N, Giganti MJ, Chew KW, Shaw-Saliba K, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With Coronavirus Disease 2019.
    Clin Infect Dis. 2024 Jul 17:ciae324. doi: 10.1093.
    >> Share

  62. JOHNSTON TS, Hage C, Abedon AT, Panda S, et al
    Rapid Wane and Recovery of XBB Sublineage Neutralization After Sequential Omicron-based Vaccination in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2024 Jul 2:ciae279. doi: 10.1093.
    >> Share

    June 2024

  63. Rapid Guidelines to Address the Changing COVID-19 Pandemic.
    Clin Infect Dis. 2024;78:e81-e82.
    >> Share

  64. CHONG C, Wee LE, Jin X, Zhang M, et al
    Risks of SARS-CoV-2 JN.1 infection and COVID-19 associated emergency-department (ED) visits/hospitalizations following updated boosters and prior infection: a population-based cohort study.
    Clin Infect Dis. 2024 Jun 26:ciae339. doi: 10.1093.
    >> Share

  65. FUSCO D, Malenica I, Gunthard HF, Gupta SK, et al
    Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison from Two Large, Open-Label Studies.
    Clin Infect Dis. 2024 Jun 26:ciae336. doi: 10.1093.
    >> Share

  66. ZENG G, Zhou Y
    Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection.
    Clin Infect Dis. 2024 Jun 26:ciae342. doi: 10.1093.
    >> Share

  67. SISE ME, Santos JR, Goldman JD, Tuttle KR, et al
    Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial.
    Clin Infect Dis. 2024 Jun 24:ciae333. doi: 10.1093.
    >> Share

  68. EPSTEIN L
    An Ounce of Prevention Is Worth a Pound of Cure: The LEAP Fellowship.
    Clin Infect Dis. 2024;78:1542-1543.
    >> Share

  69. DIAMOND C
    The Belt Parkway.
    Clin Infect Dis. 2024;78:1399-1400.
    >> Share

  70. FOWLER VG JR, Durack DT, Suty-Selton C, Miro JM, et al
    Reply to Author.
    Clin Infect Dis. 2024;78:1779.
    >> Share

  71. FUNDERBURG NT, Shive CL, Lederman MM
    Reply to Chen et al.
    Clin Infect Dis. 2024;78:1776-1777.
    >> Share

  72. YAN L, Bui D, Li Y, Rajeevan N, et al
    Identifying Veterans Who Benefit From Nirmatrelvir-Ritonavir: A Target Trial Emulation.
    Clin Infect Dis. 2024 Jun 12:ciae202. doi: 10.1093.
    >> Share

  73. OLTOLINI C, Travi G, Mikulska M
    The impact of prior COVID-19 on non-infectious endothelial complications following allogeneic hematopoietic stem cell transplantation.
    Clin Infect Dis. 2024 Jun 5:ciae307. doi: 10.1093.
    >> Share

  74. NIMGAONKAR I, Flaherty PW, Oshima MU, Hill JA, et al
    Acute Endothelial Complications Post-Allogeneic Hematopoietic Cell Transplant in Patients with Pre-Cellular Therapy SARS-CoV-2 Infection.
    Clin Infect Dis. 2024 Jun 4:ciae310. doi: 10.1093.
    >> Share


  75. Correction to: Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019.
    Clin Infect Dis. 2024 Jun 4:ciae257. doi: 10.1093.
    >> Share

  76. BOECKH M, Pergam SA, Limaye AP, Englund J, et al
    How Immunocompromised Hosts Were Left Behind in the Quest to Control the Covid-19 Pandemic.
    Clin Infect Dis. 2024 Jun 3:ciae308. doi: 10.1093.
    >> Share

    May 2024
  77. WOLFE DN, Arangies E, David GL, Armstrong B, et al
    Development of Next-Generation COVID-19 Vaccines: BARDA Supported Phase 2b Study Designs.
    Clin Infect Dis. 2024 May 28:ciae286. doi: 10.1093.
    >> Share

  78. HILL JA, Martens MJ, Young JH, Bhavsar K, et al
    SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study.
    Clin Infect Dis. 2024 May 27:ciae291. doi: 10.1093.
    >> Share

  79. LEE TC, Boulware DR
    Is there room for metformin at COVID-19's dinner table? Updated Analysis of Clinical Trials.
    Clin Infect Dis. 2024 May 17:ciae284. doi: 10.1093.
    >> Share

  80. RABIN AS, Marr LC, Blumberg HM
    Doff Thy Gown - Shedding Contact Precautions for COVID-19.
    Clin Infect Dis. 2024 May 15:ciae276. doi: 10.1093.
    >> Share

  81. SCHMITT SK
    IDSA's Letter to the American Board of Internal Medicine.
    Clin Infect Dis. 2024;78:1099-1100.
    >> Share

  82. LEE MSL
    The Pandemic Babies.
    Clin Infect Dis. 2024;78:1088-1089.
    >> Share

  83. HAMILL M, Ghanem KG, Tuddenham S
    Reply to: Cortes-Penfield and Musher.
    Clin Infect Dis. 2024;78:1387-1388.
    >> Share

  84. CASADEVALL A, Focosi D
    Anti-Spike monoclonal antibody monotherapies and immune escape risk minimization strategies.
    Clin Infect Dis. 2024 May 13:ciae254. doi: 10.1093.
    >> Share

  85. ANDREWS JS, Boonyaratanakornkit JB, Krusinska E, Allen S, et al
    Assessment of the Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection (PASC): A Randomized Phase 2 Trial of RSLV-132.
    Clin Infect Dis. 2024 May 10:ciae205. doi: 10.1093.
    >> Share

  86. JORGENSEN SCJ, Brown K, Clarke AE, Schwartz KL, et al
    The Effect of COVID-19 Vaccination on Outpatient Antibiotic Prescribing in Older Adults: A Self-Controlled Risk-Interval Study.
    Clin Infect Dis. 2024 May 3:ciae182. doi: 10.1093.
    >> Share

  87. BRAMANTE CT, Beckman KB, Mehta T, Karger AB, et al
    Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019.
    Clin Infect Dis. 2024 May 1:ciae159. doi: 10.1093.
    >> Share

  88. SIEDNER MJ, Sax PE
    Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019.
    Clin Infect Dis. 2024 May 1:ciae154. doi: 10.1093.
    >> Share

    April 2024

  89. Correction to: Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2024 Apr 30:ciae164. doi: 10.1093.
    >> Share


  90. Correction to: Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology.
    Clin Infect Dis. 2024 Apr 30:ciae166. doi: 10.1093.
    >> Share

  91. VASCONCELOS A, King JD, Nunes-Alves C, Anderson R, et al
    Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?
    Clin Infect Dis. 2024;78.
    >> Share

  92. CHUA KP, Fischer MA, Rahman M, Linder JA, et al
    Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the Coronavirus Disease 2019 Outbreak: An Interrupted Time Series Analysis of 2016-2021 Data.
    Clin Infect Dis. 2024 Apr 22:ciae135. doi: 10.1093.
    >> Share


  93. Correction to: Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients.
    Clin Infect Dis. 2024 Apr 15:ciae165. doi: 10.1093.
    >> Share

  94. RUBIS AB, Cole M, Tondella ML, Pawloski LC, et al
    Assessing the Impact of the 2020 Council of State and Territorial Epidemiologists Case Definition for Pertussis on Reported Pertussis Cases.
    Clin Infect Dis. 2024 Apr 12:ciae207. doi: 10.1093.
    >> Share

  95. PETROS BA, Milliren CE, Sabeti PC, Ozonoff A, et al
    Increased Pediatric Respiratory Syncytial Virus Case Counts Following the Emergence of Severe Acute Respiratory Syndrome Coronavirus 2 Can Be Attributed to Changes in Testing.
    Clin Infect Dis. 2024 Apr 11:ciae140. doi: 10.1093.
    >> Share

  96. SHERMAN A, Tuan J, Cantos VD, Adeyiga O, et al
    COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
    Clin Infect Dis. 2024 Apr 10:ciae192. doi: 10.1093.
    >> Share

  97. ZAWADZKA S
    Family Ties and COVID Lies.
    Clin Infect Dis. 2024;78:813-814.
    >> Share

  98. MCAULEY JB
    COVID at the Whiteriver Indian Hospital.
    Clin Infect Dis. 2024;78:815-817.
    >> Share

  99. CHABALA C, Wobudeya E, van der Zalm MM, Kapasa M, et al
    Clinical outcomes in children living with HIV treated for non-severe tuberculosis in the SHINE Trial.
    Clin Infect Dis. 2024 Apr 9:ciae193. doi: 10.1093.
    >> Share

    March 2024
  100. TERZIC V, Miantezila Basilua J, Billard N, de Gastines L, et al
    Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19): A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial.
    Clin Infect Dis. 2024 Mar 29:ciae170. doi: 10.1093.
    >> Share

  101. GOTTLIEB RL, Kalil AC
    True DisCoVeRy of COVID-19 Disease Burden Versus Speculated Antiviral Cardiovascular Risk Requires a Control Group.
    Clin Infect Dis. 2024 Mar 29:ciae172. doi: 10.1093.
    >> Share

  102. ROSTAD CA, Atmar RL, Walter EB, Frey S, et al
    A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US
    Clin Infect Dis. 2024 Mar 27:ciae173. doi: 10.1093.
    >> Share

  103. FUNK A, Florin TA, Kuppermann N, Finkelstein Y, et al
    Household Transmission Dynamics of Asymptomatic SARS-CoV-2-Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study.
    Clin Infect Dis. 2024 Mar 26:ciae069. doi: 10.1093.
    >> Share

  104. KOLBERG L, Khanijau A, van der Velden FJS, Herberg J, et al
    Raising AWaRe-ness of Antimicrobial Stewardship Challenges in Pediatric Emergency Care: Results from the PERFORM Study Assessing Consistency and Appropriateness of Antibiotic Prescribing Across Europe.
    Clin Infect Dis. 2024;78:526-534.
    >> Share

  105. GOHEEN MM
    Growing Up COVID.
    Clin Infect Dis. 2024;78:496-498.
    >> Share

  106. HAYDEN MK, El Mikati IK, Hanson KE, Englund JA, et al
    Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing.
    Clin Infect Dis. 2024 Mar 15:ciae121. doi: 10.1093.
    >> Share

  107. ROMINE JK, Li H, Coughlin MM, Jones JM, et al
    Hybrid immunity and SARS-CoV-2 antibodies: results of the HEROES-RECOVER prospective cohort study.
    Clin Infect Dis. 2024 Mar 11:ciae130. doi: 10.1093.
    >> Share

  108. ROWAN CM, LaBere B, Young CC, Zambrano LD, et al
    Pre-existing Immunocompromising Conditions and Outcomes of Acute COVID-19 Patients Admitted for Pediatric Intensive Care.
    Clin Infect Dis. 2024 Mar 11:ciae133. doi: 10.1093.
    >> Share

  109. SHRESTHA NK, Burke PC, Nowacki AS, Gordon SM, et al
    Effectiveness of the 2023-2024 Formulation of the Coronavirus Disease 2019 mRNA Vaccine.
    Clin Infect Dis. 2024 Mar 11:ciae132. doi: 10.1093.
    >> Share

  110. WENZEL RP
    Reflections on COVID-19: Solitude and Isolation.
    Clin Infect Dis. 2024 Mar 7:ciae099. doi: 10.1093.
    >> Share

  111. HUYGENS S, GeurtsvanKessel C, Gharbharan A, Bogers S, et al
    Clinical and Virological Outcome of Monoclonal Antibody Therapies Across Severe Acute Respiratory Syndrome Coronavirus 2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study.
    Clin Infect Dis. 2024 Mar 6:ciae026. doi: 10.1093.
    >> Share

  112. NIMGAONKAR I, Yoke LH, Roychoudhury P, Flaherty PW, et al
    Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T Cell Therapy Recipients with Pre-Cellular Therapy SARS-CoV-2 Infection.
    Clin Infect Dis. 2024 Mar 1:ciae116. doi: 10.1093.
    >> Share

    February 2024
  113. SHAH MM, Joyce B, Plumb ID, Sahakian S, et al
    Combined protection of vaccination and nirmatrelvir-ritonavir against hospitalization in adults with COVID-19.
    Clin Infect Dis. 2024 Feb 27:ciae105. doi: 10.1093.
    >> Share

  114. KARMARKAR EN, Fitzpatrick T, Himmelfarb ST, Chow EJ, et al
    Cluster of non-toxigenic Corynebacterium diphtheriae infective endocarditis and rising background C. diphtheriae cases-Seattle, Washington 2020-2023.
    Clin Infect Dis. 2024 Feb 21:ciae094. doi: 10.1093.
    >> Share

  115. TOWNLEY B, Akin D, Dimaguila GL, Sawires R, et al
    Exploring the infectious contribution to intussusception causality using the effects of COVID-19 lockdowns in Australia: An ecological study.
    Clin Infect Dis. 2024 Feb 20:ciae084. doi: 10.1093.
    >> Share

  116. AGGARWAL NR, Nordwall J, Braun DL, Chung L, et al
    Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
    Clin Infect Dis. 2024 Feb 20:ciad780. doi: 10.1093.
    >> Share

  117. TROSEID M
    Viral, Host Factors or Both as Coronavirus Disease 2019 (COVID-19) Biomarkers.
    Clin Infect Dis. 2024 Feb 20:ciad779. doi: 10.1093.
    >> Share

  118. FOLLMANN D, Mateja A, Fay MP, Magaret CA, et al
    Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine.
    Clin Infect Dis. 2024 Feb 19:ciae081. doi: 10.1093.
    >> Share

  119. MONTEJANO R, Arribas JR
    COVID-19 Clinical Trials: Are Adaptive Methodologies the Solution?
    Clin Infect Dis. 2024 Feb 17:ciae079. doi: 10.1093.
    >> Share

  120. GIACOMELLI A, Antinori S, Gori A, Cozzi-Lepri A, et al
    COVID-19: find the right questions to be answered.
    Clin Infect Dis. 2024 Feb 17:ciae078. doi: 10.1093.
    >> Share

  121. KOMOROWSKI AS, Lo CKL, Kapoor AK, Smieja M, et al
    More Than a Decade Since the Latest CONSORT Non-inferiority Trials Extension: Do Infectious Diseases Trials Do Enough?
    Clin Infect Dis. 2024;78:324-329.
    >> Share

  122. TOEPFER AP, Amarin JZ, Spieker AJ, Stewart LS, et al
    Seasonality, clinical characteristics, and outcomes of respiratory syncytial virus disease by subtype among children less than five years old, New Vaccine Surveillance Network, United States, 2016-2020.
    Clin Infect Dis. 2024 Feb 15:ciae085. doi: 10.1093.
    >> Share

  123. HOFMEYER KA, Ventura CL, Armstrong KL, Houchens CR, et al
    Project NexGen: Developing the Next Generation of COVID-19 Vaccines and Therapeutics to Respond to the Present and Prepare for the Future.
    Clin Infect Dis. 2024 Feb 13:ciae073. doi: 10.1093.
    >> Share

  124. MCCONEGHY KW, Hur K, Dahabreh IJ, Jiang R, et al
    Early Mortality After the First Dose of Coronavirus Disease 2019 Vaccination: A Target Trial Emulation.
    Clin Infect Dis. 2024 Feb 6:ciad604. doi: 10.1093.
    >> Share

    January 2024
  125. RYBOLT L, Oehler RL, Khalil FK, Khalil B, et al
    A 22-Year-Old With a Left Apical Chest Mass.
    Clin Infect Dis. 2024;78:199-201.
    >> Share

  126. HSUEH K, Teherani A, Guzman-Cottrill JA
    The Leaders in Epidemiology, Antimicrobial Stewardship, and Public Health (LEAP) Fellowship, a Novel Training Program in Public Health for Infectious Diseases Physicians.
    Clin Infect Dis. 2024 Jan 24:ciad787. doi: 10.1093.
    >> Share

  127. KEEHNER J, Abeles SR, Longhurst CA, Horton LE, et al
    Integrated Genomic and Social Network Analyses of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in the Healthcare Setting.
    Clin Infect Dis. 2024 Jan 16:ciad738. doi: 10.1093.
    >> Share

  128. NACHMAN S, Aldrovandi G
    Breastfeeding in the United States Among Women With HIV: Con Viewpoint.
    Clin Infect Dis. 2024 Jan 8:ciad778. doi: 10.1093.
    >> Share

  129. HEDBERG P, Valik JK, Halim LA, Alfven T, et al
    Reducing Diagnostic Bias Through Multiplex Polymerase Chain Reaction (PCR) Testing for SARS-CoV-2, Influenza A/B, and RSV.
    Clin Infect Dis. 2024 Jan 4:ciad747. doi: 10.1093.
    >> Share

  130. HARBOE ZB, Holler JG, Eiberg MF, Roed C, et al
    Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant, Influenza, and Respiratory Syncytial Virus on the Dissecting Table: Is Further Dissection Required?
    Clin Infect Dis. 2024 Jan 4:ciad739. doi: 10.1093.
    >> Share

  131. LEVY ME, Burrows E, Chilunda V, Pawloski PA, et al
    SARS-CoV-2 Antiviral Prescribing Gaps Among Non-Hospitalized High-Risk Adults.
    Clin Infect Dis. 2024 Jan 3:ciad796. doi: 10.1093.
    >> Share

    December 2023
  132. LAFONT E, Blez D, Bildan MA, Veyer D, et al
    Nirmatrelvir and Ritonavir combination in COVID-19 patients with advanced chronic kidney disease.
    Clin Infect Dis. 2023 Dec 30:ciad785. doi: 10.1093.
    >> Share

  133. VAN DER VAART TW, Prins JM, Goorhuis A, Lemkes BA, et al
    The utility of risk factors to define complicated Staphylococcus aureus bacteremia in a setting with low MRSA prevalence.
    Clin Infect Dis. 2023 Dec 29:ciad784. doi: 10.1093.
    >> Share

  134. ABEGAZ FA, Dos Santos PT, Mogeni OD, Guarnacci T, et al
    Evaluating Quality Management and Diagnostics Microbiology Performance Within an International External Quality Assessment (EQA) Program Serving National One Health Sector Reference Laboratories Across Asia: Experience Amid the Coronavirus Disease 201
    Clin Infect Dis. 2023;77.
    >> Share

  135. KWON SY, Gautam S, Poudel K, Banneheke H, et al
    Utility and Evaluation of Applied Project Management Processes Within a Large Multicountry Health Systems Development Project Conducted During the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Clin Infect Dis. 2023;77.
    >> Share

  136. MUSTAFA T, Niazi MRK, Lakdawala Z, Mirza S, et al
    Regional and National Trends in Consumption of Antimicrobials in Pakistan; Pre and Post-COVID (2019-2021).
    Clin Infect Dis. 2023;77.
    >> Share

  137. LESLIE T, Parry C, Ondoa P, Walsh T, et al
    The Reality of Antimicrobial Resistance and Antibiotic Usage Data in Asia: The CAPTURA Experience.
    Clin Infect Dis. 2023;77.
    >> Share

  138. POPOVICH KJ, Aureden K, Ham DC, Harris AD, et al
    Reply to Diekema et al. "Are contact precautions "essential" for the prevention of healthcare-associated methicillin-resistant Staphylococcus aureus?".
    Clin Infect Dis. 2023 Dec 20:ciad777. doi: 10.1093.
    >> Share

  139. HAYDEN MK, Hanson KE, Englund JA, Lee MJ, et al
    The Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019 (COVID-19): Molecular Diagnostic Testing.
    Clin Infect Dis. 2023 Dec 19:ciad646. doi: 10.1093.
    >> Share

  140. ROSE MR, Dowdy DW
    High Specificity and Low Prevalence - Important Context for HIV Testing in US Cancer Patients.
    Clin Infect Dis. 2023 Dec 19:ciad774. doi: 10.1093.
    >> Share

  141. SMITH TC
    Long COVID: Alice Evans, Brucellosis, and Reflections on Infectious Causes of Chronic Disease.
    Clin Infect Dis. 2023;77:1644-1647.
    >> Share

  142. SCIENCE M, Orkin J, Maguire B, Bitnun A, et al
    Viral dynamics of the SARS-CoV-2 Omicron Variant in Paediatric Patients; A prospective cohort study.
    Clin Infect Dis. 2023 Dec 12:ciad740. doi: 10.1093.
    >> Share

  143. RYBAK A, Assad Z, Levy C, Bonarcorsi S, et al
    Age-specific resurgence in invasive pneumococcal disease incidence in the COVID-19 pandemic era and its association with respiratory virus and pneumococcal carriage dynamics: a time series analysis.
    Clin Infect Dis. 2023 Dec 6:ciad746. doi: 10.1093.
    >> Share

  144. MAKAM AN
    Unlinking time zero from test-negative controls exaggerates risk from COVID-19.
    Clin Infect Dis. 2023 Dec 6:ciad731. doi: 10.1093.
    >> Share

  145. KOW CS, Ramachandram DS, Hasan SS, Thiruchelvam K, et al
    COVID-19 Vaccination: Safeguarding Against Post-COVID Cardiovascular Complications.
    Clin Infect Dis. 2023 Dec 6:ciad732. doi: 10.1093.
    >> Share

  146. LIM JT, En WL, Tay AT, Pang D, et al
    Unlinking time zero from test-negative date does not influence risk estimates of long-term cardiovascular complications due to COVID-19.
    Clin Infect Dis. 2023 Dec 6:ciad742. doi: 10.1093.
    >> Share

  147. LAVOIE T, Appaneal HJ, LaPlante KL
    Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention.
    Clin Infect Dis. 2023;77.
    >> Share

  148. LEWIS NM, Zhu Y, Peltan ID, Gaglani M, et al
    Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
    Clin Infect Dis. 2023 Dec 5:ciad677. doi: 10.1093.
    >> Share

  149. HOFFMANN CJ, Shearer K, Kekana B, Kerrigan D, et al
    Reducing HIV-associated post-hospital mortality through home-based care in South Africa: a randomized controlled trial.
    Clin Infect Dis. 2023 Dec 5:ciad727. doi: 10.1093.
    >> Share

    November 2023
  150. JAIN V
    Infection Control and Prevention During the COVID-19 Pandemic.
    Clin Infect Dis. 2023 Nov 30:ciad611. doi: 10.1093.
    >> Share

  151. GRANEROD J, Huang Y, Davies NWS, Sequeira PC, et al
    Global Landscape of Encephalitis: Key Priorities to Reduce Future Disease Burden.
    Clin Infect Dis. 2023;77:1552-1560.
    >> Share

  152. USDAN L, Patel S, Rodriguez H, Xu X, et al
    A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in >/=12-Year-Olds.
    Clin Infect Dis. 2023 Nov 28:ciad718. doi: 10.1093.
    >> Share

  153. LEE N, Nguyen L, Austin PC, Brown KA, et al
    Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults.
    Clin Infect Dis. 2023 Nov 24:ciad716. doi: 10.1093.
    >> Share

  154. BOULWARE DR
    When Someone Should Do Something About This: How a Cryptococcal Clinical Trialist Became Involved With the Coronavirus Disease 2019 Pandemic.
    Clin Infect Dis. 2023 Nov 16:ciad648. doi: 10.1093.
    >> Share

  155. HERBERT C, Manabe YC, Filippaios A, Lin H, et al
    Differential Viral Dynamics by Sex and Body Mass Index During Acute SARS-CoV-2 Infection: Results from a Longitudinal Cohort Study.
    Clin Infect Dis. 2023 Nov 16:ciad701. doi: 10.1093.
    >> Share

  156. SMITH-JEFFCOAT SE, Biddle JE, Talbot HK, Morrisey KG, et al
    Symptoms, viral loads, and rebound among COVID-19 outpatients treated with nirmatrelvir/ritonavir compared to propensity score matched untreated individuals.
    Clin Infect Dis. 2023 Nov 14:ciad696. doi: 10.1093.
    >> Share

  157. KANJILAL S
    Flying Into the Future With Large Language Models.
    Clin Infect Dis. 2023 Nov 14:ciad635. doi: 10.1093.
    >> Share

  158. SPINELLI MA, Christopoulos KA, Moreira CV, Jain JP, et al
    Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2023 Nov 14:ciad657. doi: 10.1093.
    >> Share

  159. MEYEROWITZ EA, Li Y
    Review: The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses.
    Clin Infect Dis. 2023 Nov 9:ciad685. doi: 10.1093.
    >> Share

  160. SAAG MS
    Coronavirus Disease (COVID) and the Fog of War.
    Clin Infect Dis. 2023 Nov 8:ciad649. doi: 10.1093.
    >> Share

  161. TIPPETT A, Ess G, Hussaini L, Reese O, et al
    Influenza Vaccine Effectiveness Pre-pandemic among Adults Hospitalized with Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and Older Adults.
    Clin Infect Dis. 2023 Nov 8:ciad679. doi: 10.1093.
    >> Share

  162. KUPPALLI K
    Hostility Unmasked: Scientists on the Frontlines of the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Clin Infect Dis. 2023 Nov 6:ciad623. doi: 10.1093.
    >> Share

  163. HUMPHRIES R, Sefers S, Schmitz J, Seegmiller A, et al
    Clinical Laboratory Experiences During the Coronavirus Disease 2019 Pandemic.
    Clin Infect Dis. 2023 Nov 2:ciad622. doi: 10.1093.
    >> Share

  164. ASLAM S
    Phage Therapy in Lung Transplantation: Current Status and Future Possibilities.
    Clin Infect Dis. 2023;77.
    >> Share

    October 2023
  165. DE KRETSER D, Mora J, Bloomfield M, Campbell A, et al
    Early oral antibiotic switch in Staphylococcus aureus bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol.
    Clin Infect Dis. 2023 Oct 31:ciad666. doi: 10.1093.
    >> Share

  166. KUUT TA, Muller F, Csorba I, Braamse AMJ, et al
    Letter to the editor: Positive effects of cognitive-behavioral therapy targeting severe fatigue following COVID-19 are sustained up to one year after treatment.
    Clin Infect Dis. 2023 Oct 27:ciad661. doi: 10.1093.
    >> Share

  167. HEDBERG P, Karlsson Valik J, Abdel Halim L, Alfven T, et al
    Outcomes of SARS-CoV-2 Omicron Variant Infections Compared with Seasonal Influenza and Respiratory Syncytial Virus Infections in Adults Attending the Emergency Department: A Multicentre Cohort Study.
    Clin Infect Dis. 2023 Oct 26:ciad660. doi: 10.1093.
    >> Share

  168. MONTEJANO R, Soler-Carracedo A, Borobia AM, Martin-Quiros A, et al
    The Current Mismatch between COVID-19 Clinical Trial Design and The Evolving Profile of Hospitalized Patients: A Retrospective Cohort Analysis.
    Clin Infect Dis. 2023 Oct 26:ciad655. doi: 10.1093.
    >> Share

  169. HAMAD Y, Bell TD, Kadri SS
    Shifting Tides: Is It Time to Embrace Adjunctive Corticosteroids for Community-Acquired Pneumonia?
    Clin Infect Dis. 2023 Oct 25:ciad498. doi: 10.1093.
    >> Share

  170. APPEL KS, Geisler R, Maier D, Miljukov O, et al
    A Systematic Review of Predictor Composition, Outcomes, Risk of Bias, and Validation of COVID-19 Prognostic Scores.
    Clin Infect Dis. 2023 Oct 25:ciad618. doi: 10.1093.
    >> Share

  171. RHEE C, Strich JR, Chiotos K, Classen DC, et al
    Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper.
    Clin Infect Dis. 2023 Oct 13:ciad447. doi: 10.1093.
    >> Share

  172. GREEN SI, Clark JR, Santos HH, Weesner KE, et al
    A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes.
    Clin Infect Dis. 2023;77:1079-1091.
    >> Share

  173. CARAZO S, Guay CA, Skowronski DM, Amini R, et al
    Influenza hospitalization burden by subtype, age, comorbidity and vaccination status: 2012/13 to 2018/19 seasons, Quebec, Canada.
    Clin Infect Dis. 2023 Oct 11:ciad627. doi: 10.1093.
    >> Share

  174. ISLAM J, Hu W
    Heatwaves and Dengue Outbreak in Bangladesh after COVID-19 Pandemic- An Urgent Call for Climate-Driven Early Warning Systems.
    Clin Infect Dis. 2023 Oct 10:ciad625. doi: 10.1093.
    >> Share

  175. STIER EA, Jain M, Joshi H, Darragh TM, et al
    Two-Year Incidence and Cumulative Risk and Predictors of Anal High-Grade Squamous Intraepithelial Lesions (anal precancer) among Women with HIV.
    Clin Infect Dis. 2023 Oct 8:ciad614. doi: 10.1093.
    >> Share

  176. SCHUSTER JE, Hamdan L, Dulek DE, Kitko CL, et al
    The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial.
    Clin Infect Dis. 2023 Oct 6:ciad534. doi: 10.1093.
    >> Share

  177. CONLY JM, Loeb M
    SARS-CoV-2 Exposures in a Large Gathering Event and Acquisition of COVID-19 in the Post-Vaccintion Era: A Randomized Trial is Possible During the Pandemic.
    Clin Infect Dis. 2023 Oct 5:ciad609. doi: 10.1093.
    >> Share

  178. LUONG NGUYEN LB, Goupil de Bouille J, Menant L, Noret M, et al
    A randomised controlled trial to study the transmission of SARS-CoV-2 and other respiratory viruses during indoor clubbing events (ANRS0066s ITOC study).
    Clin Infect Dis. 2023 Oct 5:ciad603. doi: 10.1093.
    >> Share

  179. BIERE-RAFI S, Janssen K, Jurgens E, Kooij S, et al
    Is Cognitive Behavioural Therapy Effective for Post-COVID Fatigue?
    Clin Infect Dis. 2023;77:1074-1075.
    >> Share

  180. MCCREARY EK
    Our "Side Hustle".
    Clin Infect Dis. 2023 Oct 4:ciad543. doi: 10.1093.
    >> Share

  181. GOFF DA
    Isolated and Lonely in a Nursing Home During the COVID 19 Pandemic: A Deadly Combination for My Mom.
    Clin Infect Dis. 2023 Oct 4:ciad591. doi: 10.1093.
    >> Share

  182. REGAN NN
    Just Breathe: My First 12 Hours as a Clinician Patient With COVID-19.
    Clin Infect Dis. 2023 Oct 4:ciad573. doi: 10.1093.
    >> Share

  183. MARCELIN GE, Marcelin NL, Marcelin JR, Marcelin A, et al
    Our parents were never home: seeing the pandemic through children's eyes.
    Clin Infect Dis. 2023 Oct 4:ciad564. doi: 10.1093.
    >> Share

    September 2023
  184. FREDIANI JK, Parsons R, McLendon KB, Westbrook AL, et al
    The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs.
    Clin Infect Dis. 2023 Sep 28:ciad582. doi: 10.1093.
    >> Share

  185. GUPTA A, Hughes MD, Cruz JL, Avihingsanon A, et al
    Adverse Pregnancy Outcomes among HIV-infected Women Taking Isoniazid Preventive Therapy During the First Trimester.
    Clin Infect Dis. 2023 Sep 28:ciad583. doi: 10.1093.
    >> Share

  186. LOPEZ BERNAL J, Andrews N, Gower C, Stowe J, et al
    Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From Coronavirus Disease 2019 in Adults Aged >/=70 Years.
    Clin Infect Dis. 2023 Sep 27:ciab881. doi: 10.1093.
    >> Share

  187. LIM JT, En WL, Tay AT, Pang D, et al
    Long-term Cardiovascular, Cerebrovascular, and Other Thrombotic Complications in Coronavirus Disease 2019 Survivors: A Retrospective Cohort Study.
    Clin Infect Dis. 2023 Sep 25:ciad469. doi: 10.1093.
    >> Share

  188. ANDERSSON NW, Thiesson EM, Lassauniere R, Hansen JV, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Postacute Risk of Non-Coronavirus Disease 2019 Infectious Disease Hospitalizations: A Nationwide Cohort Study of Danish Adults Aged >/=50 Years.
    Clin Infect Dis. 2023 Sep 22:ciad531. doi: 10.1093.
    >> Share

  189. WALKER J, McCarty T, McGwin G, Ordaya EE, et al
    Description of Cryptococcosis following SARS-CoV-2 infection: A disease survey through the Mycosis Study Group Education and Research Consortium (MSG-19).
    Clin Infect Dis. 2023 Sep 15:ciad551. doi: 10.1093.
    >> Share

  190. FEYS S, Lagrou K, Lauwers HM, Haenen K, et al
    High burden of COVID-19-associated pulmonary aspergillosis (CAPA) in severely immunocompromised patients requiring mechanical ventilation.
    Clin Infect Dis. 2023 Sep 11:ciad546. doi: 10.1093.
    >> Share

  191. DZIECIOLOWSKA S, Charest H, Roy T, Fafard J, et al
    Timing and Predictors of Loss of Infectivity among Healthcare Workers with Mild Primary and Recurrent COVID-19: a Prospective Observational Cohort Study.
    Clin Infect Dis. 2023 Sep 7:ciad535. doi: 10.1093.
    >> Share

    August 2023
  192. WONG CKH, Lau KTK, Au ICH, Lau EHY, et al
    Comparison of bivalent and monovalent mRNA vaccine boosters.
    Clin Infect Dis. 2023 Aug 30:ciad519. doi: 10.1093.
    >> Share

  193. LAM T, Saso A, Ortiz AT, Hatcher J, et al
    The Socio-Economic and Demographic Risk Factors for SARS-CoV-2 Seropositivity Among Healthcare Workers in a UK Hospital: A Prospective Cohort Study.
    Clin Infect Dis. 2023 Aug 30:ciad522. doi: 10.1093.
    >> Share

  194. GRIGGS EP, Mitchell PK, Lazariu V, Gaglani M, et al
    Clinical epidemiology and risk factors for critical outcomes among vaccinated and unvaccinated adults hospitalized with COVID-19-VISION Network, 10 States, June 2021-March 2023.
    Clin Infect Dis. 2023 Aug 26:ciad505. doi: 10.1093.
    >> Share

  195. BRUMMER LE, Thompson RR, Malhotra A, Shrestha S, et al
    Cost effectiveness of low-complexity screening tests in community-based case-finding for tuberculosis.
    Clin Infect Dis. 2023 Aug 25:ciad501. doi: 10.1093.
    >> Share

  196. GENTRY CA, Nguyen PN, Thind SK, Kurdgelashvili G, et al
    Characteristics and outcomes of US Veterans with immunocompromised conditions at high risk of severe SARS-CoV-2 infection with or without receipt of oral antiviral agents.
    Clin Infect Dis. 2023 Aug 24:ciad504. doi: 10.1093.
    >> Share

  197. KINAMON T, Gopinath R, Waack U, Needles M, et al
    Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-Abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs.
    Clin Infect Dis. 2023;77:649-656.
    >> Share

  198. ZUCKERMAN NS, Bucris E, Keidar-Friedman D, Amsalem M, et al
    Nirmatrelvir resistance - de novo E166V/L50V mutations in an immunocompromised patient treated with prolonged nirmatrelvir/ritonavir monotherapy leading to clinical and virological treatment failure - a case report.
    Clin Infect Dis. 2023 Aug 19:ciad494. doi: 10.1093.
    >> Share

  199. TATE JE, Mwenda JM, Keita AM, Tapsoba TW, et al
    Evaluation of Intussusception Following Pentavalent Rotavirus Vaccine (RotaTeq) Administration in Five Countries in Africa.
    Clin Infect Dis. 2023 Aug 19:ciad492. doi: 10.1093.
    >> Share

  200. SOTO CL, Hsu AJ, Lee JH, Dzintars K, et al
    Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study.
    Clin Infect Dis. 2023 Aug 16:ciad476. doi: 10.1093.
    >> Share

  201. LIANG TJ, Law JLM, Pietschmann T, Ray SC, et al
    Challenge Inoculum for Hepatitis C Virus Controlled Human Infection Model.
    Clin Infect Dis. 2023;77.
    >> Share

  202. CYBULSKI DJ, Matthews Z, Kieffer JW, Casey TM, et al
    Impact of SARS-CoV-2 Arrival Surveillance Screening by Nucleic Acid Amplification Versus Rapid Antigen Detection on Subsequent COVID-19 Infections in Military Trainees.
    Clin Infect Dis. 2023 Aug 10:ciad466. doi: 10.1093.
    >> Share

  203. MOZAFFARI E, Chandak A, Gottlieb RL, Chima-Melton C, et al
    Remdesivir reduced mortality in immunocompromised patients hospitalized for COVID-19 across variant waves: Findings from routine clinical practice.
    Clin Infect Dis. 2023 Aug 9:ciad460. doi: 10.1093.
    >> Share

  204. UNO S, Goto R, Honda K, Uchida S, et al
    The cost-effectiveness of universal asymptomatic preoperative SARS-CoV-2 PCR screening: a cost-utility analysis.
    Clin Infect Dis. 2023 Aug 9:ciad463. doi: 10.1093.
    >> Share

  205. O'LEARY EN, Neuhauser MM, Srinivasan A, Dubendris H, et al
    Impact of the COVID-19 Pandemic on Inpatient Antibiotic Use in the United States, January 2019 through July 2022.
    Clin Infect Dis. 2023 Aug 3:ciad453. doi: 10.1093.
    >> Share

  206. EHRENZELLER S, Chen T, Vaidya V, Rhee C, et al
    Impact of SARS-CoV-2 Prevention Measures on Non-SARS-CoV-2 Hospital-Onset Respiratory Viral Infections: An Incidence Trend Analysis from 2015-2023.
    Clin Infect Dis. 2023 Aug 2:ciad451. doi: 10.1093.
    >> Share

  207. CHAN GCK, Lui GCY, Wong CNS, Yip SST, et al
    Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2023 Aug 2:ciad371. doi: 10.1093.
    >> Share

    July 2023
  208. POZZI C, Sarti R, Levi R, Mollura M, et al
    Association between duration of SARS-CoV-2 positivity and long COVID.
    Clin Infect Dis. 2023 Jul 22:ciad434. doi: 10.1093.
    >> Share

  209. SAYAMA Y, Okamoto M, Saito M, Tamaki R, et al
    Lack of zoonotic coronavirus species detected among children hospitalized with pneumonia in the Philippines.
    Clin Infect Dis. 2023 Jul 20:ciad430. doi: 10.1093.
    >> Share

  210. BRUST K, Kobayashi T, Diekema DJ
    Asymptomatic testing of hospital admissions for SARS-CoV-2: Is it OK to stop?
    Clin Infect Dis. 2023 Jul 18:ciad423. doi: 10.1093.
    >> Share

  211. RHEE C, Klompas M, Pak TR, Kohler JR, et al
    In Support of Universal Admission Testing for SARS-CoV-2 During Significant Community Transmission.
    Clin Infect Dis. 2023 Jul 18:ciad424. doi: 10.1093.
    >> Share

  212. NARAYANASAMY S, Curtis LH, Hernandez AF, Woods CW, et al
    Lessons from COVID-19 for Pandemic Preparedness: Proceedings from a Multi-Stakeholder Think Tank.
    Clin Infect Dis. 2023 Jul 12:ciad418. doi: 10.1093.
    >> Share

  213. ALLAN-BLITZ LT, Klausner JD
    SARS-CoV-2 Case-Definitions Must Include Clinical Criteria: Reply to Kojima et al.
    Clin Infect Dis. 2023 Jul 7:ciad413. doi: 10.1093.
    >> Share

  214. ALLEL K, Peters A, Conejeros J, Martinez JRW, et al
    Antibiotic Consumption During the Coronavirus Disease 2019 Pandemic and Emergence of Carbapenemase-Producing Klebsiella pneumoniae Lineages Among Inpatients in a Chilean Hospital: A Time-Series Study and Phylogenomic Analysis.
    Clin Infect Dis. 2023;77.
    >> Share

  215. SOLANKY D, McGovern OL, Edwards JR, Mahon G, et al
    Prescribing of Outpatient Antibiotics Commonly Used for Respiratory Infections Among Adults Before and During the Coronavirus Disease 2019 Pandemic in Brazil.
    Clin Infect Dis. 2023;77.
    >> Share

  216. RAMAY BM, Castillo C, Grajeda L, Santos LF, et al
    Colonization With Antibiotic-Resistant Bacteria in a Hospital and Associated Communities in Guatemala: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Clin Infect Dis. 2023;77.
    >> Share

  217. BEZERRA CLPAM, Dos Santos EL, Oliveira MS, Dias MBS, et al
    Crude Mortality Associated With the Empirical Use of Polymyxins in Septic Patients in a Setting of High Prevalence of Carbapenem-Resistant Gram-negative Bacteria: Retrospective Analysis of a Cohort.
    Clin Infect Dis. 2023;77.
    >> Share

  218. ARAOS R, Smith RM, Styczynski A, Sanchez F, et al
    High Burden of Intestinal Colonization With Antimicrobial-Resistant Bacteria in Chile: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Clin Infect Dis. 2023;77.
    >> Share

  219. PATEL TS, McGovern OL, Mahon G, Osuka H, et al
    Trends in Inpatient Antibiotic Use Among Adults Hospitalized During the Coronavirus Disease 2019 Pandemic in Argentina, Brazil, and Chile, 2018-2021.
    Clin Infect Dis. 2023;77.
    >> Share

  220. KIFFER CRV, Rezende TFT, Costa-Nobre DT, Marinonio ASS, et al
    A 7-Year Brazilian National Perspective on Plasmid-Mediated Carbapenem Resistance in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex and the Impact of the Coronavirus Disease 2019 Pandemic on Their Occurrence.
    Clin Infect Dis. 2023;77.
    >> Share

  221. FOCOSI D, Franchini M, Nicastri E, Sullivan DJ, et al
    Convalescent Plasma Versus Hyperimmune Immunoglobulins.
    Clin Infect Dis. 2023 Jul 3:ciad406. doi: 10.1093.
    >> Share

  222. BAERENDS EAM, Reekie J, Andreasen SR, Staerke NB, et al
    Omicron variant-specific serological imprinting following BA.1 or BA.4/5 bivalent vaccination and previous SARS-CoV-2 infection: A cohort study.
    Clin Infect Dis. 2023 Jul 1:ciad402. doi: 10.1093.
    >> Share

    June 2023
  223. CRAWFORD JS
    Correspondence in relation to the recently published paper: Efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19: results of a randomized controlled trial by Kuut and colleagues.
    Clin Infect Dis. 2023 Jun 30:ciad397. doi: 10.1093.
    >> Share

  224. EVANS ME, Simbartl LA, McCauley BP, Flarida LK, et al
    Active Surveillance and Contact Precautions for Preventing Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections during the COVID-19 Pandemic.
    Clin Infect Dis. 2023 Jun 30:ciad388. doi: 10.1093.
    >> Share

  225. FAUST JS, Kumar A, Shah J, Khadke S, et al
    Oral Nirmatrelvir and Ritonavir for Covid-19 in Vaccinated, Non-Hospitalized Adults, Ages 18-50 Years.
    Clin Infect Dis. 2023 Jun 30:ciad400. doi: 10.1093.
    >> Share

  226. MELGAR M, Abrams JY, Godfred-Cato S, Shah AB, et al
    A multicenter retrospective cohort study to characterize patients hospitalized with MIS-A and COVID-19 in the United States, 2020-2021.
    Clin Infect Dis. 2023 Jun 29:ciad374. doi: 10.1093.
    >> Share

  227. AMBROGGIO L, Cotter J, Hall M, Shapiro DJ, et al
    Management of Pediatric Pneumonia: A Decade After the PIDS/IDSA Guideline.
    Clin Infect Dis. 2023 Jun 23:ciad385. doi: 10.1093.
    >> Share

  228. TROTTIER C, La J, Li LL, Alsoubani M, et al
    Maintaining the Utility of COVID-19 Pandemic Severity Surveillance: Evaluation of Trends in Attributable Deaths and Development and Validation of a Measurement Tool.
    Clin Infect Dis. 2023 Jun 22:ciad381. doi: 10.1093.
    >> Share

  229. UPASANI V, Townsend K, Wu MY, Carr EJ, et al
    Commercial immunoglobulin products contain neutralising antibodies against SARS-CoV-2 spike protein.
    Clin Infect Dis. 2023 Jun 20:ciad368. doi: 10.1093.
    >> Share

  230. SENEFELD JW, Joyner MJ
    SARS-CoV-2 Antibody Replacement Therapy for Immunocompromised Patients.
    Clin Infect Dis. 2023 Jun 20:ciad367. doi: 10.1093.
    >> Share

  231. NAFICY A, Kuxhausen A, Pirrotta P, Leav B, et al
    No immunological interference or safety concerns when adjuvanted recombinant zoster vaccine is coadministered with a COVID-19 mRNA-1273 booster vaccine in adults aged 50 years and older: A randomized trial.
    Clin Infect Dis. 2023 Jun 19:ciad361. doi: 10.1093.
    >> Share

  232. GUAN Y, Puenpatom A, Johnson MG, Zhang Y, et al
    Impact of Molnupiravir Treatment on Patient-Reported Coronavirus Disease 2019 (COVID-19) Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial.
    Clin Infect Dis. 2023 Jun 19:ciad409. doi: 10.1093.
    >> Share

  233. MONTASTRUC F, de Canecaude C
    Tixagevimab-Cilgavimab Treatment and Cardiovascular Events: Immortal Time Bias.
    Clin Infect Dis. 2023;76:2044-2045.
    >> Share

  234. ISRAEL A, Berkovitch M, Merzon E, Golan-Cohen A, et al
    Glucose-6-phosphate dehydrogenase (G6PD) Deficiency and COVID-19.
    Clin Infect Dis. 2023 Jun 7:ciad348. doi: 10.1093.
    >> Share

  235. WEE LE, Pang D, Chiew C, Tan J, et al
    Long-term real-world protection afforded by third mRNA doses against symptomatic SARS-COV-2 infections, COVID-19-related emergency attendances and hospitalizations amongst older Singaporeans during an Omicron XBB wave.
    Clin Infect Dis. 2023 Jun 6:ciad345. doi: 10.1093.
    >> Share

  236. JILG N, Chew KW, Giganti MJ, Daar ES, et al
    One Week of Oral Camostat Versus Placebo in Non-Hospitalized Adults with Mild-to-Moderate COVID-19: A Randomized Controlled Phase 2 Trial.
    Clin Infect Dis. 2023 Jun 5:ciad342. doi: 10.1093.
    >> Share

    May 2023
  237. LUNDGREN J
    Patients Hospitalized With Coronavirus Disease 2019: A Diverse Population.
    Clin Infect Dis. 2023 May 31:ciad280. doi: 10.1093.
    >> Share

  238. KOJIMA N, Adams K, Self WH, Gaglani M, et al
    Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
    Clin Infect Dis. 2023 May 31:ciad276. doi: 10.1093.
    >> Share


  239. Correction to: Relative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Period-Un
    Clin Infect Dis. 2023 May 30:ciad256. doi: 10.1093.
    >> Share

  240. ASTURIAS EJ, Excler JL, Ackland J, Cavaleri M, et al
    Safety of Streptococcus pyogenes vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post Marketing Monitoring.
    Clin Infect Dis. 2023 May 26:ciad311. doi: 10.1093.
    >> Share

  241. DEL AMO J
    Question of Whether Tenofovir Disoproxil Fumarate/Emtricitabine Provides Protection Against Clinical Severity of Coronavirus Disease 2019.
    Clin Infect Dis. 2023;76:1735-1737.
    >> Share

  242. TEJERINA F, Palomino R, Catalan P, Sanz A, et al
    Longitudinal Whole-Genome Sequence Characterization of a Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.5 Infection in an Immunocompromised Patient Successfully Treated With Sotrovimab 1000 mg.
    Clin Infect Dis. 2023;76:1872-1874.
    >> Share

  243. BLENNOW O, Vesterbacka J, Tovatt T, Nowak P, et al
    Successful Combination Treatment for Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Clin Infect Dis. 2023;76:1864-1865.
    >> Share

  244. MAOR Y, Shinar E, Izak M, Rahav G, et al
    A Randomized Controlled Study Assessing Convalescent Immunoglobulins versus Convalescent Plasma for Hospitalized COVID-19 Patients.
    Clin Infect Dis. 2023 May 23:ciad305. doi: 10.1093.
    >> Share

  245. GOWTHAMAN P, Vasoo S
    Zinc for the treatment of COVID-19: Yet to prove its mettle?
    Clin Infect Dis. 2023 May 22:ciad303. doi: 10.1093.
    >> Share

  246. YADAW AS, Sahner DK, Sidky H, Afzali B, et al
    Pre-existing autoimmunity is associated with increased severity of COVID-19: A retrospective cohort study using data from the National COVID Cohort Collaborative (N3C).
    Clin Infect Dis. 2023 May 19:ciad294. doi: 10.1093.
    >> Share


  247. Correction to: Association of Upper Respiratory Streptococcus pneumoniae Colonization With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Adults.
    Clin Infect Dis. 2023 May 18:ciad191. doi: 10.1093.
    >> Share

  248. ZENG G, Zhou Y
    Association of virus variation and vaccination status with post-acute sequelae after SARS-cov-2 infection.
    Clin Infect Dis. 2023 May 10:ciad292. doi: 10.1093.
    >> Share

  249. GUDIPATI S, Shallal A, Peterson E, Cook B, et al
    Increase in False Positive Fourth Generation HIV Tests in Patients with COVID-19 Disease.
    Clin Infect Dis. 2023 May 9:ciad264. doi: 10.1093.
    >> Share

  250. WAALEWIJN H, Szubert AJ, Wasmann RE, Wiesner L, et al
    First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.
    Clin Infect Dis. 2023 May 9:ciad267. doi: 10.1093.
    >> Share

  251. KUUT TA, Muller F, Csorba I, Braamse A, et al
    Efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19: results of a randomized controlled trial.
    Clin Infect Dis. 2023 May 8:ciad257. doi: 10.1093.
    >> Share

  252. KABORE JL, Laffont B, Diop M, Tardif MR, et al
    Real-World Effectiveness of Nirmatrelvir/Ritonavir on Covid-19-Associated Hospitalization Prevention: A Population-Based Cohort Study in the Province of Quebec, Canada.
    Clin Infect Dis. 2023 May 7:ciad287. doi: 10.1093.
    >> Share

  253. KO JY, Pham H, Anglin O, Chai SJ, et al
    Vaccination Status and Trends in Adult COVID-19-Associated Hospitalizations by Race and Ethnicity, March 2020-August 2022.
    Clin Infect Dis. 2023 May 3:ciad266. doi: 10.1093.
    >> Share

  254. TIMIRE C, Pedrazzoli D, Boccia D, Houben RM, et al
    Use of a sustainable livelihood framework-based measure to estimate socioeconomic impact of tuberculosis on house-holds.
    Clin Infect Dis. 2023 May 3:ciad273. doi: 10.1093.
    >> Share

  255. HASSANZADEH H, Baber J, Begier E, Noriega DC, et al
    Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STRIVE Randomized Clinical Trial.
    Clin Infect Dis. 2023 May 1:ciad218. doi: 10.1093.
    >> Share

    April 2023
  256. ADALJA A, McQuillen DP, Meyer D
    How Infectious Disease Experts Impacted the Coronavirus Disease 2019 (COVID-19) Response: Lessons From the Front Lines.
    Clin Infect Dis. 2023 Apr 27:ciad137. doi: 10.1093.
    >> Share

  257. GVINJILIA L, Baliashvili D, Shadaker S, Averhoff F, et al
    Impact of HCV infection and treatment on mortality in the country of Georgia, 2015-2020.
    Clin Infect Dis. 2023 Apr 26:ciad182. doi: 10.1093.
    >> Share

  258. GLEESON SE, Zapata H, Bathgate ME, Emu B, et al
    Building an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and Reflections.
    Clin Infect Dis. 2023 Apr 20:ciad236. doi: 10.1093.
    >> Share

  259. HAIDAR G, Jacobs JL, Hughes Kramer K, Naqvi A, et al
    Therapy with Allogeneic SARS-CoV-2-specific T-cells for Persistent COVID-19 in Immunocompromised Patients.
    Clin Infect Dis. 2023 Apr 20:ciad233. doi: 10.1093.
    >> Share

  260. KLAASSEN F, Chitwood MH, Cohen T, Pitzer VE, et al
    Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022.
    Clin Infect Dis. 2023 Apr 19:ciad210. doi: 10.1093.
    >> Share

  261. ERTEM Z, Nelson RE, Schechter-Perkins EM, Al-Amery A, et al
    Condition-Dependent and Dynamic Impacts of Indoor Masking Policies for COVID-19 Mitigation: A Nationwide, Interrupted Time-Series Analysis.
    Clin Infect Dis. 2023 Apr 19:ciad115. doi: 10.1093.
    >> Share

  262. JOFFE AR, Elliott A, Eapen R, Milburn C, et al
    Is vaccination acting as a placebo in preventing symptoms of Long-COVID?
    Clin Infect Dis. 2023 Apr 19:ciad234. doi: 10.1093.
    >> Share

  263. SWINDELLS S, Eschenauer GA, Nason M, Daar ES, et al
    Letter to the Editor.
    Clin Infect Dis. 2023 Apr 19:ciad229. doi: 10.1093.
    >> Share

  264. SABET N, Omar T, Milovanovic M, Magajane T, et al
    Undiagnosed pulmonary TB and COVID in adults dying at home in a high TB burden setting, before and during pandemic COVID-19: an autopsy study.
    Clin Infect Dis. 2023 Apr 12:ciad212. doi: 10.1093.
    >> Share

  265. OSTROSKY-ZEICHNER L
    COVID-19: Shehecheyanu.
    Clin Infect Dis. 2023 Apr 11:ciad213. doi: 10.1093.
    >> Share

  266. BRANCHE AR, Rouphael NG, Losada C, Baden LR, et al
    Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial.
    Clin Infect Dis. 2023 Apr 10:ciad209. doi: 10.1093.
    >> Share

  267. SCHWARTZ IS, Bahr NC
    Out of Bounds: A Critical Appraisal of the Changing Geography of the Endemic Mycoses.
    Clin Infect Dis. 2023;76:1302-1303.
    >> Share

    March 2023
  268. WERBEL WA, Weld ED, Advani SD, Patel PK, et al
    Your outpatient has COVID-19: what are their treatment options in the current SARS-CoV-2 variant climate?
    Clin Infect Dis. 2023 Mar 31:ciad178. doi: 10.1093.
    >> Share

  269. MACFADDEN DR, Maxwell C, Bowdish D, Bronskill S, et al
    COVID-19 Vaccination is Associated with Reduced Outpatient Antibiotic Prescribing In Older Adults with Confirmed SARS-CoV-2: A Population Wide Cohort Study.
    Clin Infect Dis. 2023 Mar 31:ciad190. doi: 10.1093.
    >> Share

  270. LEVITT JE, Hedlin H, Duong S, Lu D, et al
    Evaluation of acebilustat, a selective inhibitor of leukotriene B4 biosynthesis, for treatment of outpatients with mild-moderate COVID-19 disease: A randomized, double-blind, placebo- controlled Phase 2 trial.
    Clin Infect Dis. 2023 Mar 30:ciad187. doi: 10.1093.
    >> Share

  271. BLOCH EM, Goel R, Zhu X, Patel EU, et al
    COVID-19 convalescent plasma utilization in the United States: data from the National Inpatient Sample.
    Clin Infect Dis. 2023 Mar 29:ciad185. doi: 10.1093.
    >> Share

  272. MIKULSKA M, Sepulcri C, Dentone C, Magne F, et al
    Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients.
    Clin Infect Dis. 2023 Mar 28:ciad181. doi: 10.1093.
    >> Share

  273. FERREIRA VH, Ierullo M, Mavandadnejad F, Kurtesi A, et al
    Omicron BA.4/5 neutralization and T-cell responses in organ transplant recipients after Booster mRNA vaccine: a Multicenter Cohort Study.
    Clin Infect Dis. 2023 Mar 28:ciad175. doi: 10.1093.
    >> Share

  274. PEREZ MOLINA JA, Crespillo-Andujar C, Zamora J, Fernandez-Felix BM, et al
    Contribution of low CD4 cell counts and high HIV viral load to the efficacy of preferred first-line antiretroviral regimens for treating HIV infection: A systematic review and meta-analysis.
    Clin Infect Dis. 2023 Mar 28:ciad177. doi: 10.1093.
    >> Share

  275. VAN EFFELTERRE T, Hens N, White LJ, Gravenstein S, et al
    Modeling Respiratory Syncytial Virus Adult Vaccination in the United States with a Dynamic Transmission Model.
    Clin Infect Dis. 2023 Mar 23:ciad161. doi: 10.1093.
    >> Share

  276. OELTMANN JE, Vohra D, Matulewicz HH, DeLuca N, et al
    Isolation and quarantine for COVID-19 in the United States, 2020-2022.
    Clin Infect Dis. 2023 Mar 22:ciad163. doi: 10.1093.
    >> Share

  277. OSBORN R, Alamri M, Tomic R, Ison MG, et al
    Infectious Complications of Lung Transplant for COVID-Associated Lung Injury (CALI): A Single Center Case-Control Cohort Study.
    Clin Infect Dis. 2023 Mar 21:ciad160. doi: 10.1093.
    >> Share

  278. WANG P, Xing H, Zhang X, Yang J, et al
    Complexity Interactions between Nirmatrelvir/Ritonavir and Voriconazole in Patients with Coronavirus Disease 2019.
    Clin Infect Dis. 2023 Mar 21:ciad159. doi: 10.1093.
    >> Share

  279. CHUNG H, Campitelli MA, Buchan SA, Campigotto A, et al
    Evaluating the impact of statin use on influenza vaccine effectiveness and influenza infection in older adults.
    Clin Infect Dis. 2023 Mar 21:ciad148. doi: 10.1093.
    >> Share

  280. MORI N, Hirai J, Asai N, Mikamo H, et al
    Appropriate outcome settings for the effectiveness of oral zinc treatment for Coronavirus Disease-2019.
    Clin Infect Dis. 2023 Mar 17:ciad153. doi: 10.1093.
    >> Share


  281. Correction to: Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada.
    Clin Infect Dis. 2023 Mar 15:ciac607. doi: 10.1093.
    >> Share

  282. LEWER D, Brothers TD, Croxford S, Desai M, et al
    Opioid injection-associated bacterial infections in England, 2002-2021: a time series analysis of seasonal variation and the impact of COVID-19.
    Clin Infect Dis. 2023 Mar 14:ciad144. doi: 10.1093.
    >> Share

  283. KAHLERT CR, Strahm C, Gusewell S, Cusini A, et al
    Post-acute sequelae after SARS-CoV-2 infection by viral variant and vaccination status: a multicenter cross-sectional study.
    Clin Infect Dis. 2023 Mar 11:ciad143. doi: 10.1093.
    >> Share

  284. NIRENBERG E, Perencevich EN
    Understanding and Improving Vaccine Effectiveness Estimates in the Age of Widespread Background Immunity: A Step Towards Improved Science Communication.
    Clin Infect Dis. 2023 Mar 8:ciad124. doi: 10.1093.
    >> Share

  285. RON R, Moreno E, Martinez-Sanz J, Branas F, et al
    CD4/CD8 ratio during HIV treatment: time for routine monitoring?
    Clin Infect Dis. 2023 Mar 8:ciad136. doi: 10.1093.
    >> Share

  286. PATEL R, Tsalik EL, Evans S, Fowler VG, et al
    Clinically Adjudicated Reference Standards for Evaluation of Infectious Diseases Diagnostics.
    Clin Infect Dis. 2023;76:938-943.
    >> Share

  287. MARCELIN JR, Khazanchi R, Lyden E, Cawcutt KA, et al
    Demographic Representation Among Speakers and Program Committee Members at the IDWeek Conference, 2013-2021.
    Clin Infect Dis. 2023;76:897-904.
    >> Share

  288. LEA AN, Leyden WA, Sofrygin O, Marafino BJ, et al
    Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 (COVID-19) Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.
    Clin Infect Dis. 2023 Mar 2:ciad084. doi: 10.1093.
    >> Share

  289. DEL AMO J
    Question of Whether Tenofovir Disoproxil Fumarate/Emtricitabine Provides Protection Against Clinical Severity of Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2023 Mar 2:ciad086. doi: 10.1093.
    >> Share


  290. Correction to: Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients.
    Clin Infect Dis. 2023 Mar 1:ciac702. doi: 10.1093.
    >> Share


  291. Correction to: Effectiveness of Messenger RNA-based Vaccines During the Emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant.
    Clin Infect Dis. 2023 Mar 1:ciac810. doi: 10.1093.
    >> Share

    February 2023
  292. PANDIT JA, Radin JM, Chiang D, Spencer EG, et al
    The COVID-19 Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences in Participants Treated with Nirmatrelvir Plus Ritonavir Versus Untreated Controls.
    Clin Infect Dis. 2023 Feb 22:ciad102. doi: 10.1093.
    >> Share

  293. SHOHAM S
    COVID-19 Convalescent Plasma Reaches the Slope of Enlightenment in the Gartner Hype Cycle.
    Clin Infect Dis. 2023 Feb 21:ciad092. doi: 10.1093.
    >> Share

  294. LEVINE AC, Fukuta Y, Huaman MA, Ou J, et al
    COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized Trials.
    Clin Infect Dis. 2023 Feb 21:ciad088. doi: 10.1093.
    >> Share

  295. TEJERINA F, Palomino R, Catalan P, Sanz A, et al
    Longitudinal whole-genome sequence characterization of a persistent SARS-CoV-2 Omicron BA.5 infection in an immunocompromised patient successfully treated with sotrovimab 1000 mg.
    Clin Infect Dis. 2023 Feb 17:ciad090. doi: 10.1093.
    >> Share

  296. NALINTYA E, Sekar P, Kavuma P, Kigozi J, et al
    Effect of Covid-19 lockdowns on identification of advanced HIV disease in outpatient clinics in Uganda.
    Clin Infect Dis. 2023 Feb 17:ciad087. doi: 10.1093.
    >> Share

  297. HEMILA H, Chalker E
    Zinc and COVID-19.
    Clin Infect Dis. 2023 Feb 14:ciad078. doi: 10.1093.
    >> Share

  298. BLENNOW O, Vesterbacka J, Tovatt T, Nowak P, et al
    Successful combination treatment for persistent SARS-CoV-2 infection.
    Clin Infect Dis. 2023 Feb 14:ciad085. doi: 10.1093.
    >> Share

  299. CABRAL SM, Harris AD, Cosgrove SE, Magder LS, et al
    Adherence to Antimicrobial Prophylaxis Guidelines for Elective Surgeries across 825 United States Hospitals, 2019-2020.
    Clin Infect Dis. 2023 Feb 12:ciad077. doi: 10.1093.
    >> Share

  300. FRUTOS AM, Kuan G, Lopez R, Ojeda S, et al
    Infection-induced immunity is associated with protection against SARS-CoV-2 infection and decreased infectivity.
    Clin Infect Dis. 2023 Feb 12:ciad074. doi: 10.1093.
    >> Share

  301. MORAWSKA L, Bahnfleth W, Bluyssen PM, Boerstra A, et al
    COVID-19 and Airborne Transmission: Science Rejected, Lives Lost. Can Society Do Better?
    Clin Infect Dis. 2023 Feb 10:ciad068. doi: 10.1093.
    >> Share


  302. It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2023 Feb 10:ciac612. doi: 10.1093.
    >> Share

  303. OKUMURA K, Jyothula S, Kaleekal T, Dhand A, et al
    One-year Outcomes of Lung Transplantation for COVID-19 Associated End Stage Lung Disease in the United States.
    Clin Infect Dis. 2023 Feb 9:ciad072. doi: 10.1093.
    >> Share


  304. Correction to: Coronavirus Disease 2019 [COVID-19] Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study.
    Clin Infect Dis. 2023 Feb 8:ciac632. doi: 10.1093.
    >> Share

  305. KOMPANIYETS L, Wiegand RE, Oyalowo AC, Bull-Otterson L, et al
    Relative effectiveness of COVID-19 vaccination and booster dose combinations among 18.9 million vaccinated adults during the early SARS-CoV-2 Omicron period - United States, January 1, 2022-March 31, 2022.
    Clin Infect Dis. 2023 Feb 8:ciad063. doi: 10.1093.
    >> Share

  306. KORPE P, Ni Z, Kabir M, Alam M, et al
    Prospective cohort study of Cryptosporidium infection and shedding in infants and their households.
    Clin Infect Dis. 2023 Feb 8:ciad059. doi: 10.1093.
    >> Share

  307. WILDENTHAL JA, Atkinson A, Lewis S, Sayood S, et al
    Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs.
    Clin Infect Dis. 2023;76:487-496.
    >> Share

  308. TORRICO F, Gascon J, Ortiz L, Pinto J, et al
    A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease.
    Clin Infect Dis. 2023;76:e1186-e1194.
    >> Share

  309. MORGAN DJ, Dubberke ER, Hink T, Paszkiewicz G, et al
    The Impact of Universal Glove and Gown Use on Clostridioides Difficile Acquisition: A Cluster-Randomized Trial.
    Clin Infect Dis. 2023;76:e1202-e1207.
    >> Share

  310. SCHIAFFINO F, Colston JM, Paredes Olortegui M, Rengifo Pinedo S, et al
    Antibiotic Use and Stewardship Practices in a Pediatric Community-based Cohort Study in Peru: Shorter Would be Sweeter.
    Clin Infect Dis. 2023;76:e1054-e1061.
    >> Share

  311. JUNKER D, Becker M, Wagner TR, Kaiser PD, et al
    Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants.
    Clin Infect Dis. 2023;76:e240-e249.
    >> Share

  312. BLOCH EM, Focosi D, Shoham S, Senefeld J, et al
    Guidance on the use of convalescent plasma to treat immunocompromised patients with COVID-19.
    Clin Infect Dis. 2023 Feb 6:ciad066. doi: 10.1093.
    >> Share


  313. Correction to: Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial.
    Clin Infect Dis. 2023 Feb 3:ciad014. doi: 10.1093.
    >> Share

  314. SCHULTZ JS, Mace KE, Tan KR
    Return to travel in the COVID-19 pandemic recovery period and implications for imported malaria: Reinforcing prevention, early diagnosis, and appropriate treatment of malaria.
    Clin Infect Dis. 2023 Feb 1:ciad061. doi: 10.1093.
    >> Share

    January 2023
  315. HERNANDEZ-TAMAYO C, Qato DM, Jewell MP, Gounder P, et al
    COVID-19 Pandemic Associated Declines and Subsequent Increases in Hepatitis C Virus Treatment Prescriptions in Los Angeles County.
    Clin Infect Dis. 2023 Jan 31:ciad050. doi: 10.1093.
    >> Share

  316. MOLLDREM S
    Research on the Development of SARS-CoV-2 Variants of Concern in People with Advanced HIV Disease Should Highlight Structural Conditions and Avoid Harmful Stereotypes.
    Clin Infect Dis. 2023 Jan 31:ciad048. doi: 10.1093.
    >> Share

  317. GOTTLIEB M, Wang R, Yu H, Spatz ES, et al
    Severe Fatigue and Persistent Symptoms at Three Months Following SARS-CoV-2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.
    Clin Infect Dis. 2023 Jan 27:ciad045. doi: 10.1093.
    >> Share

  318. MELICA G, Bartolucci P, Audureau E, Le Corvoisier P, et al
    Immunological efficacy of pneumococcal vaccination including the 13-valent pneumococcal vaccine in adult patients with sickle-cell disease: results of the randomized DREVAC controlled trial.
    Clin Infect Dis. 2023 Jan 27:ciad037. doi: 10.1093.
    >> Share

  319. HAYDEN MK, Hanson KE, Englund JA, Lee F, et al
    The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing.
    Clin Infect Dis. 2023 Jan 26:ciad032. doi: 10.1093.
    >> Share


  320. Correction to: Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada.
    Clin Infect Dis. 2023 Jan 18:ciac584. doi: 10.1093.
    >> Share

  321. BONAZZETTI C, Tazza B, Gibertoni D, Pasquini Z, et al
    Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort.
    Clin Infect Dis. 2023 Jan 13:ciad016. doi: 10.1093.
    >> Share

  322. STEELE EJ, Gorczynski RM, Lindley RA, Wickramasinghe NC, et al
    Natural Antibodies and SARS CoV-2 Specific Antibodies in Healthy Asymptomatic Individuals.
    Clin Infect Dis. 2023 Jan 10:ciad004. doi: 10.1093.
    >> Share


  323. Correction to: Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer.
    Clin Infect Dis. 2023 Jan 6:ciac964. doi: 10.1093.
    >> Share

  324. DALTON AF, Weber ZA, Allen KS, Stenehjem E, et al
    Relationships between social vulnerability and COVID-19 vaccination coverage and vaccine effectiveness.
    Clin Infect Dis. 2023 Jan 6:ciad003. doi: 10.1093.
    >> Share

  325. TITANJI BK
    The Last Mile Problem - COVID-19 Vaccine Coverage Among the Most Socially Vulnerable.
    Clin Infect Dis. 2023 Jan 6:ciad006. doi: 10.1093.
    >> Share

  326. DEDRICK RM, Smith BE, Cristinziano M, Freeman KG, et al
    Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease.
    Clin Infect Dis. 2023;76:103-112.
    >> Share

  327. MALCHAIR P, Giol J, Garcia V, Rodriguez O, et al
    Three-day icatibant on top of standard care in patients with COVID-19 pneumonia (ICAT.COVID): a randomized, open-label, phase 2, proof-of-concept trial.
    Clin Infect Dis. 2023 Jan 4:ciac984. doi: 10.1093.
    >> Share

    December 2022

  328. Correction to: Potential Influence of Menstrual Status and Sex Hormones on Female Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Cross-sectional Multicenter Study in Wuhan, China.
    Clin Infect Dis. 2022 Dec 31:ciac576. doi: 10.1093.
    >> Share

  329. HERRING MK, Romine JK, Wesley MG, Ellingson KD, et al
    SARS-CoV-2 infection history and antibody response to three COVID-19 mRNA vaccine doses.
    Clin Infect Dis. 2022 Dec 29:ciac976. doi: 10.1093.
    >> Share

  330. SPATZ ES, Gottlieb M, Wisk LE, Anderson J, et al
    Three-month symptom profiles among symptomatic adults with positive and negative SARS-CoV-2 tests: a prospective cohort study from the INSPIRE group.
    Clin Infect Dis. 2022 Dec 27:ciac966. doi: 10.1093.
    >> Share

  331. ROBERTSON MM, Qasmieh SA, Kulkarni SG, Teasdale CA, et al
    The epidemiology of long COVID in US adults.
    Clin Infect Dis. 2022 Dec 21:ciac961. doi: 10.1093.
    >> Share

  332. VUORIO A, Kovanen PT, Raal F
    Statin Needs to be Continued During Paxlovid Therapy in COVID-19.
    Clin Infect Dis. 2022;75:2281-2282.
    >> Share

  333. ROBINSON ML, Morris CP, Betz JF, Zhang Y, et al
    Impact of SARS-CoV-2 variants on inpatient clinical outcome.
    Clin Infect Dis. 2022 Dec 19:ciac957. doi: 10.1093.
    >> Share

  334. CHOWERS M, Gerassy-Vainberg S, Cohen-Poradosu R, Wiener-Well Y, et al
    The Effect of Macrolides on Mortality in Bacteremic Pneumococcal Pneumonia: A Retrospective, Nationwide Cohort Study, Israel, 2009-2017.
    Clin Infect Dis. 2022;75:2219-2224.
    >> Share

  335. NEHME M, Vetter P, Chappuis F, Kaiser L, et al
    Prevalence of post-COVID Condition 12 Weeks after Omicron Infection Compared to Negative Controls and Association with Vaccination Status.
    Clin Infect Dis. 2022 Dec 15:ciac947. doi: 10.1093.
    >> Share

  336. PRICE AM, Flannery B, Talbot HK, Grijalva CG, et al
    Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season.
    Clin Infect Dis. 2022 Dec 12:ciac941. doi: 10.1093.
    >> Share

  337. HETRICH MK, Oliva J, Wanionek K, Knoll MD, et al
    Epidemiology of human parainfluenza virus type 3 (HPIV-3) and respiratory syncytial virus (RSV) infections in the time of COVID-19: findings from a household cohort in Maryland.
    Clin Infect Dis. 2022 Dec 12:ciac942. doi: 10.1093.
    >> Share

  338. PRUNAS O, Weinberger DM, Pitzer VE, Gazit S, et al
    Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents in Israel.
    Clin Infect Dis. 2022 Dec 9:ciac315. doi: 10.1093.
    >> Share

  339. EDWARDS KM, Neuzil KM
    Developing mucosal vaccines for SARS-CoV-2: What will it take?
    Clin Infect Dis. 2022 Dec 9:ciac935. doi: 10.1093.
    >> Share

  340. COHEN JI, Dropulic L, Wang K, Gangler K, et al
    Comparison of levels of nasal, salivary, and plasma antibody to SARS-CoV-2 during natural infection and after vaccination.
    Clin Infect Dis. 2022 Dec 9:ciac934. doi: 10.1093.
    >> Share

  341. MUKAE H, Yotsuyanagi H, Ohmagari N, Doi Y, et al
    Efficacy and safety of ensitrelvir in patients with mild-to-moderate COVID-19: the phase 2b part of a randomized, placebo-controlled, phase 2/3 study.
    Clin Infect Dis. 2022 Dec 7:ciac933. doi: 10.1093.
    >> Share

  342. JASSAT W, Abdool Karim SS, Ozougwu L, Welch R, et al
    Trends in Cases, Hospitalization and Mortality Related to the Omicron BA.4/BA.5 Sub-Variants in South Africa.
    Clin Infect Dis. 2022 Dec 1:ciac921. doi: 10.1093.
    >> Share


  343. Correction to: Leveraging Serosurveillance and Postmortem Surveillance to Quantify the Impact of Coronavirus Disease 2019 in Africa.
    Clin Infect Dis. 2022 Dec 1:ciac897. doi: 10.1093.
    >> Share

    November 2022
  344. KAMIDANI S, Garg S, Rolfes MA, Campbell AP, et al
    Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in US Children Over 9 Seasons Following the 2009 H1N1 Pandemic.
    Clin Infect Dis. 2022;75:1930-1939.
    >> Share

  345. YAN J, Steiger SN, Kodama R, Fender J, et al
    Predictors of COVID-19 hospitalization after sotrovimab in hematologic malignancy patients during the BA.1 Omicron surge.
    Clin Infect Dis. 2022 Nov 29:ciac916. doi: 10.1093.
    >> Share

  346. MOKHTAR S, Parpia AS, Lo NC, Ndeffo-Mbah ML, et al
    Evaluation of the United States definitions for COVID-19 community risk levels.
    Clin Infect Dis. 2022 Nov 26:ciac922. doi: 10.1093.
    >> Share

  347. TADESSE BT, Bravo L, Marks F, Aziz AB, et al
    Impact of vaccination with SCB-2019 COVID-19 vaccine on transmission of SARS-CoV-2 infection: a household contact study in the Philippines.
    Clin Infect Dis. 2022 Nov 26:ciac914. doi: 10.1093.
    >> Share

  348. DAVIS JM, Li JZ
    The Promise and Peril of Anti-SARS-CoV-2 Monoclonal Antibodies.
    Clin Infect Dis. 2022 Nov 22:ciac902. doi: 10.1093.
    >> Share

  349. LEVIN MJ, Ustianowski A, Thomas S, Templeton A, et al
    AZD7442 (Tixagevimab/Cilgavimab) for Post-exposure Prophylaxis of Symptomatic COVID-19.
    Clin Infect Dis. 2022 Nov 22:ciac899. doi: 10.1093.
    >> Share

  350. CASKEY M, Kuritzkes DR
    Monoclonal Antibodies as Long-Acting Products: What Are We Learning From Human Immunodeficiency Virus (HIV) and Coronavirus Disease 2019 (COVID-19)?
    Clin Infect Dis. 2022;75.
    >> Share

  351. PARKER AM, Jackson N, Awasthi S, Kim H, et al
    Association of upper respiratory Streptococcus pneumoniae colonization with SARS-CoV-2 infection among adults.
    Clin Infect Dis. 2022 Nov 19:ciac907. doi: 10.1093.
    >> Share

  352. ALAEDINI A, Wormser GP
    Persistence of SARS-CoV-2 to Explain Long COVID Is Not Consistent with the Available Data.
    Clin Infect Dis. 2022 Nov 17. pii: 6831665. doi: 10.1093.
    >> Share

  353. BIRABAHARAN M, Hill E, Begur M, Kaelber DC, et al
    Cardiovascular outcomes after tixagevimab and cilgavimab use for pre-exposure prophylaxis against COVID-19: a population-based propensity-matched cohort study.
    Clin Infect Dis. 2022 Nov 16. pii: 6830248. doi: 10.1093.
    >> Share

  354. SHAH MM, Spencer BR, Feldstein LR, Haynes JM, et al
    Occupations Associated with SARS-CoV-2 Infection and Vaccination, U.S. Blood Donors, July 2021-December 2021.
    Clin Infect Dis. 2022 Nov 14. pii: 6825618. doi: 10.1093.
    >> Share

  355. PAI MANGALORE R, Ashok A, Lee SJ, Romero L, et al
    Beta-Lactam Antibiotic Therapeutic Drug Monitoring in Critically Ill Patients: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2022;75:1848-1860.
    >> Share

  356. BAKER MA, Rhee C, Tucker R, Vaidya V, et al
    Ralstonia pickettii and Pseudomonas aeruginosa Bloodstream Infections Associated With Contaminated Extracorporeal Membrane Oxygenation Water Heater Devices.
    Clin Infect Dis. 2022;75:1838-1840.
    >> Share

  357. MORRIS CP, Eldesouki RE, Sachithanandham J, Fall A, et al
    Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization.
    Clin Infect Dis. 2022 Nov 11. pii: 6822482. doi: 10.1093.
    >> Share

  358. BARDA N, Canetti M, Gilboa M, Asraf K, et al
    The Association Between Pre-Booster Vaccination Antibody Levels and the Risk of SARS-CoV-2 Infection.
    Clin Infect Dis. 2022 Nov 11. pii: 6821340. doi: 10.1093.
    >> Share

  359. BLOSSEY AM, Bruckner S, May M, Parzmair GP, et al
    VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including COVID-19 in the Elderly: a phase III randomised, double-blind, placebo-controlled, multicenter clinical study.
    Clin Infect Dis. 2022 Nov 11. pii: 6821343. doi: 10.1093.
    >> Share

  360. OTERO S, Miller ES, Sunderraj A, Shanes ED, et al
    Maternal Antibody Response and Transplacental Transfer Following SARS-CoV-2 Infection or Vaccination in Pregnancy.
    Clin Infect Dis. 2022 Nov 9. pii: 6812657. doi: 10.1093.
    >> Share

  361. YAN VC
    Test 5- versus 10-day remdesivir treatment in immunocompromised patients with COVID-19.
    Clin Infect Dis. 2022 Nov 8. pii: 6809131. doi: 10.1093.
    >> Share

  362. SIEGHART D, Hana CA, Haslacher H, Perkmann T, et al
    MULTI-PARAMETRIC PREDICTION MODELS FOR COVID-19 VACCINE SELECTION: RESULTS OF A COMPARATIVE POPULATION-BASED COHORT STUDY.
    Clin Infect Dis. 2022 Nov 4. pii: 6795267. doi: 10.1093.
    >> Share

  363. BEN ABDALLAH S, Mhalla Y, Trabelsi I, Sekma A, et al
    Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial.
    Clin Infect Dis. 2022 Nov 4. pii: 6795268. doi: 10.1093.
    >> Share

  364. HOLMGAARD FB, Guglielmetti L, Lillebaek T, Andersen AB, et al
    Efficacy and tolerability of concomitant use of bedaquiline and delamanid for multidrug- and extensively drug-resistant tuberculosis: a systematic review and meta-analysis.
    Clin Infect Dis. 2022 Nov 4. pii: 6801118. doi: 10.1093.
    >> Share

  365. SNELL LB, Medina-Alcolea A, Charalampous T, Alder C, et al
    Real-time whole genome sequencing to guide patient-tailored therapy of SARS-CoV-2 infection.
    Clin Infect Dis. 2022 Nov 3. pii: 6785897. doi: 10.1093.
    >> Share

  366. TENFORDE MW, Patel MM, Lewis NM, Adams K, et al
    Vaccine effectiveness against influenza A(H3N2)-associated hospitalized illness, United States, 2022.
    Clin Infect Dis. 2022 Nov 3. pii: 6795261. doi: 10.1093.
    >> Share

  367. FORD ES, Simmons W, Karmarkar EN, Yoke LH, et al
    Successful treatment of prolonged, severe COVID-19 lower respiratory tract disease in a B-cell ALL patient with an extended course of remdesivir and nirmatrelvir/ritonavir.
    Clin Infect Dis. 2022 Nov 3. pii: 6795102. doi: 10.1093.
    >> Share

    October 2022
  368. NAJJAR-DEBBINY R, Gronich N, Weber G, Stein N, et al
    Effectiveness of Evusheld in Immunocompromised Patients: Propensity Score-Matched Analysis.
    Clin Infect Dis. 2022 Oct 31. pii: 6780937. doi: 10.1093.
    >> Share

  369. BETTINGER JA, Irvine MA, Shulha HP, Valiquette L, et al
    Adverse Events Following Immunization with mRNA and Viral Vector Vaccines in Individuals with Previous SARS-CoV-2 Infection from the Canadian National Vaccine Safety Network.
    Clin Infect Dis. 2022 Oct 31. pii: 6780916. doi: 10.1093.
    >> Share

  370. WANG L, Calzavara A, Baral S, Smylie J, et al
    Differential patterns by area-level social determinants of health in COVID-19 related mortality and non-COVID-19 mortality: a population-based study of 11.8 million people in Ontario, Canada.
    Clin Infect Dis. 2022 Oct 28. pii: 6776118. doi: 10.1093.
    >> Share

  371. BAHR NC, Skipper CP, Huppler-Hullsiek K, Ssebambulidde K, et al
    Recurrence of symptoms following cryptococcal meningitis - characterizing a diagnostic conundrum with multiple etiologies.
    Clin Infect Dis. 2022 Oct 28. pii: 6776123. doi: 10.1093.
    >> Share

  372. LAI J, Coleman KK, Tai SS, German J, et al
    Exhaled Breath Aerosol Shedding by Highly Transmissible Versus Prior SARS-CoV-2 Variants.
    Clin Infect Dis. 2022 Oct 26. pii: 6773834. doi: 10.1093.
    >> Share

  373. TROTTIER CA, Wong B, Kohli R, Boomsma C, et al
    Dual antiviral therapy for persistent COVID-19 and associated organizing pneumonia in an immunocompromised host.
    Clin Infect Dis. 2022 Oct 25. pii: 6771205. doi: 10.1093.
    >> Share

  374. VINCETI M, Filippini T, Fairweather-Tait S
    A potential role for zinc to enhance treatment for COVID-19?
    Clin Infect Dis. 2022 Oct 25. pii: 6771230. doi: 10.1093.
    >> Share

  375. PENALVA G, Crespo-Rivas JC, Guisado-Gil AB, Rodriguez-Villodres A, et al
    Clinical and ecological impact of an educational program to optimize antibiotic treatments in nursing homes (PROA-SENIOR): a cluster randomized controlled trial and interrupted time-series analysis.
    Clin Infect Dis. 2022 Oct 21. pii: 6765270. doi: 10.1093.
    >> Share

  376. TURBETT SE, Tomkins-Tinch CH, Anahtar MN, Dugdale CM, et al
    Distinguishing SARS-CoV-2 persistence and reinfection: A retrospective cohort study.
    Clin Infect Dis. 2022 Oct 21. pii: 6765222. doi: 10.1093.
    >> Share

  377. CLARKE KEN, Hong K, Schoonveld M, Greenspan AI, et al
    Severity of COVID-19 Hospitalization Outcomes and Patient Disposition Differ by Disability Status and Disability Type.
    Clin Infect Dis. 2022 Oct 19. pii: 6763266. doi: 10.1093.
    >> Share

  378. ASARE K, Andine T, Naicker N, Dorward J, et al
    Impact of point-of-care testing on the management of sexually transmitted infections in South Africa: Evidence from the HVTN702 HIV vaccine trial.
    Clin Infect Dis. 2022 Oct 15. pii: 6761890. doi: 10.1093.
    >> Share

  379. MALOSH RE, McGovern I, Monto AS
    Influenza During the 2010-2020 Decade in the United States: Seasonal Outbreaks and Vaccine Interventions.
    Clin Infect Dis. 2022 Oct 11. pii: 6758391. doi: 10.1093.
    >> Share

  380. LI Y, Harrison LJ, Chew KW, Currier JS, et al
    Nasal and Plasma SARS-CoV-2 RNA Levels are Associated with Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19.
    Clin Infect Dis. 2022 Oct 10. pii: 6754602. doi: 10.1093.
    >> Share

  381. HEATH PT, Galiza EP, Baxter DN, Boffito M, et al
    Safety and Efficacy of the NVX-CoV2373 COVID-19 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
    Clin Infect Dis. 2022 Oct 10. pii: 6754597. doi: 10.1093.
    >> Share

  382. HAN AX, Girdwood S, Khan S, Sacks JA, et al
    Strategies for using antigen rapid diagnostic tests to reduce transmission of SARS-CoV-2 in low- and middle-income countries: a mathematical modelling study applied to Zambia.
    Clin Infect Dis. 2022 Oct 8. pii: 6754174. doi: 10.1093.
    >> Share

  383. COPPEE R, Sarrasin V, Zaffaroulah R, Bouzayene A, et al
    Nosocomial malaria transmissions resolved by genomic analyses - a retrospective case report study in France (2007-2021).
    Clin Infect Dis. 2022 Oct 8. pii: 6754169. doi: 10.1093.
    >> Share

  384. EPLING BP, Rocco JM, Boswell KL, Laidlaw E, et al
    Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment.
    Clin Infect Dis. 2022 Oct 6. pii: 6749408. doi: 10.1093.
    >> Share

  385. FIDLER S, Fox J, Tipoe T, Longet S, et al
    Booster vaccination against SARS-CoV-2 induces potent immune responses in people with HIV.
    Clin Infect Dis. 2022 Oct 5. pii: 6748267. doi: 10.1093.
    >> Share

  386. KOGAN NE, Gantt S, Swerdlow D, Viboud C, et al
    Leveraging Serosurveillance and Postmortem Surveillance to Quantify the Impact of COVID-19 in Africa.
    Clin Infect Dis. 2022 Oct 5. pii: 6748257. doi: 10.1093.
    >> Share

  387. GLIGA S, Luebke N, Killer A, Gruell H, et al
    Rapid selection of sotrovimab escape variants in SARS-CoV-2 Omicron infected immunocompromised patients.
    Clin Infect Dis. 2022 Oct 3. pii: 6746719. doi: 10.1093.
    >> Share

    September 2022
  388. VAUGHN VM, Ratz D, Greene MT, Flanders SA, et al
    Antibiotic Stewardship Strategies and Their Association With Antibiotic Overuse After Hospital Discharge: An Analysis of the Reducing Overuse of Antibiotics at Discharge (Road) Home Framework.
    Clin Infect Dis. 2022;75:1063-1072.
    >> Share

  389. STOCKWELL MS, Reed C, Vargas CY, Wang L, et al
    Five-Year Community Surveillance Study for Acute Respiratory Infections Using Text Messaging: Findings From the MoSAIC Study.
    Clin Infect Dis. 2022;75:987-995.
    >> Share

  390. HOGAN JI, Duerr R, Dimartino D, Marier C, et al
    Remdesivir resistance in transplant recipients with persistent COVID-19.
    Clin Infect Dis. 2022 Sep 26. pii: 6717535. doi: 10.1093.
    >> Share

  391. FLOREA A, Sy LS, Qian L, Ackerson BK, et al
    Effectiveness of mRNA-1273 vaccine booster against COVID-19 in immunocompetent adults.
    Clin Infect Dis. 2022 Sep 22. pii: 6711079. doi: 10.1093.
    >> Share

  392. SCHERER EM, Backer M, Carvajal K, Danziger-Isakov L, et al
    The COVID-19 Pandemic Unmasked the Challenges Faced by Early-Stage Faculty in Infectious Diseases: A Call to Action.
    Clin Infect Dis. 2022 Sep 22. pii: 6710388. doi: 10.1093.
    >> Share

  393. NAJJAR-DEBBINY R, Gronich N, Weber G, Khoury J, et al
    Effectiveness of Molnupiravir in High Risk Patients: a Propensity Score Matched Analysis.
    Clin Infect Dis. 2022 Sep 20. pii: 6708264. doi: 10.1093.
    >> Share

  394. SIANGPHOE U, Baden LR, El Sahly HM, Essink B, et al
    Associations of Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA-1273 Vaccine in COVE and TeenCOVE Trials.
    Clin Infect Dis. 2022 Sep 20. pii: 6708263. doi: 10.1093.
    >> Share

  395. ONO S, Michihata N, Yamana H, Uemura K, et al
    Comparative effectiveness of BNT162b2 and mRNA-1273 booster dose after BNT162b2 primary vaccination against the Omicron variants: A retrospective cohort study using large-scale population-based registries in Japan.
    Clin Infect Dis. 2022 Sep 18. pii: 6696997. doi: 10.1093.
    >> Share

  396. BOULWARE DR, Murray TA, Proper JL, Tignanelli CJ, et al
    Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial.
    Clin Infect Dis. 2022 Sep 17. pii: 6702474. doi: 10.1093.
    >> Share

  397. DONLAN AN, Mallawaarachi I, Sasson JM, Preissner R, et al
    Dupilumab use is associated with protection from COVID-19 mortality: A retrospective analysis.
    Clin Infect Dis. 2022 Sep 15. pii: 6698736. doi: 10.1093.
    >> Share

  398. ALONSO-NAVARRO R, Cuesta G, Santos M, Cardozo C, et al
    Qualitative Subgenomic RNA to Monitor the Response to Remdesivir in Hospitalized Patients with COVID-19: impact on the length of hospital stay and mortality.
    Clin Infect Dis. 2022 Sep 13. pii: 6696600. doi: 10.1093.
    >> Share

  399. CUOMO RE, Li Z, Purushothaman V, Basavapatna-Shankar C, et al
    Predictors of Time to COVID-19 Infection in the National Basketball Association: A Retrospective Case-Control Study.
    Clin Infect Dis. 2022 Sep 13. pii: 6696551. doi: 10.1093.
    >> Share

  400. KAKIUCHI S, Livorsi DJ, Perencevich EN, Diekema DJ, et al
    Days of Antibiotic Spectrum Coverage: A Novel Metric for Inpatient Antibiotic Consumption.
    Clin Infect Dis. 2022;75:567-576.
    >> Share

  401. MAGNUS MC, Haberg SE, Carlsen EO, Kwong JC, et al
    Pregnancy status at the time of COVID-19 vaccination and incidence of SARS-CoV-2 infection.
    Clin Infect Dis. 2022 Sep 8. pii: 6693880. doi: 10.1093.
    >> Share

  402. KOJIMA N, Klausner JD
    Usage and awareness of antiviral medications for COVID-19 among individuals at risk for severe COVID-19, March 2021 to 1 August 2022.
    Clin Infect Dis. 2022 Sep 7. pii: 6693563. doi: 10.1093.
    >> Share

  403. GOLAN Y, Campos JAS, Woolson R, Cilla D, et al
    Favipiravir in patients with early mild-to-moderate COVID-19: a randomized controlled trial.
    Clin Infect Dis. 2022 Sep 6. pii: 6692456. doi: 10.1093.
    >> Share

  404. BHIMRAJ A, Morgan RL, Shumaker AH, Baden L, et al
    Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.
    Clin Infect Dis. 2022 Sep 5. pii: 6692369. doi: 10.1093.
    >> Share

  405. SWANK Z, Senussi Y, Manickas-Hill Z, Yu XG, et al
    Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae.
    Clin Infect Dis. 2022 Sep 2. pii: 6686531. doi: 10.1093.
    >> Share

    August 2022
  406. WIRTH KE, Edwards JK, Feinstein L, Breskin A, et al
    When emulating a trial, do as the trialists do: Missteps in estimating relative effectiveness of a SARS-CoV-2 vaccine booster dose.
    Clin Infect Dis. 2022 Aug 30. pii: 6679241. doi: 10.1093.
    >> Share

  407. HARRIGAN SP, Wilton J, Chong M, Abdia Y, et al
    Clinical severity of Omicron SARS-CoV-2 variant relative to Delta in British Columbia, Canada: A retrospective analysis of whole genome sequenced cases.
    Clin Infect Dis. 2022 Aug 30. pii: 6679248. doi: 10.1093.
    >> Share

  408. YIP TCF, Lui GCY, Lai MSM, Wong VWS, et al
    Impact of the use of oral antiviral agents on the risk of hospitalization in community COVID-19 patients.
    Clin Infect Dis. 2022 Aug 29. pii: 6678124. doi: 10.1093.
    >> Share

  409. GAGLANI M, Kim SS, Naleway AL, Levine MZ, et al
    Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial.
    Clin Infect Dis. 2022 Aug 29. pii: 6678123. doi: 10.1093.
    >> Share

  410. LOHSE ZM, Shapiro JJ, Lednicky JA, Cash MN, et al
    Persistence of SARS-CoV-2 omicron variant in children and utility of rapid antigen testing as an indicator of culturable virus.
    Clin Infect Dis. 2022 Aug 27. pii: 6677545. doi: 10.1093.
    >> Share

  411. FISHER BT, Boge CLK, Xiao R, Shuster S, et al
    Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents.
    Clin Infect Dis. 2022;75:248-259.
    >> Share

  412. KLOMPAS M, Baker MA, Rhee C
    Coronavirus Disease 2019's Challenges to Infection Control Dogma Regarding Respiratory Virus Transmission.
    Clin Infect Dis. 2022;75:e102-e104.
    >> Share

  413. KLEIN B, Harris DA
    Examining the Robustness of 3 Versus 6 Feet of Physical Distancing in Schools: A Reanalysis of van den Berg et al.
    Clin Infect Dis. 2022;75:e310-e311.
    >> Share

  414. FERNANDEZ-DE-LAS-PENAS C
    Are Patients Exhibiting Post-Coronavirus Disease (COVID) Symptoms at 12 months the Same at 5 or 9 Months? The Fluctuating Nature of Post-COVID.
    Clin Infect Dis. 2022;75:e1208.
    >> Share

  415. ADVANI SD, Sickbert-Bennett E, Moehring R, Cromer A, et al
    The Disproportionate Impact of COVID-19 Pandemic on Healthcare-Associated Infections in Community Hospitals: Need for Expanding the Infectious Disease Workforce.
    Clin Infect Dis. 2022 Aug 23. pii: 6673939. doi: 10.1093.
    >> Share

  416. GANATRA S, Dani SS, Ahmad J, Kumar A, et al
    Oral Nirmatrelvir and Ritonavir in Non-hospitalized Vaccinated Patients with Covid-19.
    Clin Infect Dis. 2022 Aug 20. pii: 6672670. doi: 10.1093.
    >> Share

  417. WIEMKEN TL, McGrath LJ, Andersen KM, Khan F, et al
    COVID-19 severity and risk of subsequent cardiovascular events.
    Clin Infect Dis. 2022 Aug 19. pii: 6671924. doi: 10.1093.
    >> Share

  418. NASREEN S, Febriani Y, Velasquez Garcia HA, Zhang G, et al
    Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: A multiprovincial test-negative design study.
    Clin Infect Dis. 2022 Aug 17. pii: 6668859. doi: 10.1093.
    >> Share

  419. PERSON AK, Armstrong WS, Evans T, Fangman JJ, et al
    Principles for Ending HIV as an Epidemic in the United States: A Policy Paper of IDSA and HIVMA.
    Clin Infect Dis. 2022 Aug 15. pii: 6662275. doi: 10.1093.
    >> Share

  420. DELAHOY MJ, Munoz F, Li K, Arriola CS, et al
    SARS-CoV-2 testing and detection during peripartum hospitalizations among a multi-center cohort of pregnant persons, March 2020-February 2021.
    Clin Infect Dis. 2022 Aug 12. pii: 6663759. doi: 10.1093.
    >> Share

  421. PECK H, Anbumurali N, McMahon K, Freeman K, et al
    Detection of influenza in managed quarantine in Australia and the estimated risk of importation.
    Clin Infect Dis. 2022 Aug 12. pii: 6663754. doi: 10.1093.
    >> Share

  422. FJELLTVEIT EB, Blomberg B, Kuwelker K, Zhou F, et al
    Symptom burden and immune dynamics 6 to 18 months following mild SARS-CoV-2 infection -a case-control study.
    Clin Infect Dis. 2022 Aug 12. pii: 6663664. doi: 10.1093.
    >> Share

  423. KARABA AH, Zhou W, Li S, Aytenfisu TY, et al
    Impact of Seasonal Coronavirus Antibodies on SARS-CoV-2 Vaccine Responses in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2022 Aug 12. pii: 6663288. doi: 10.1093.
    >> Share

  424. QASMIEH SA, Robertson MM, Teasdale CA, Kulkarni SG, et al
    Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022.
    Clin Infect Dis. 2022 Aug 12. pii: 6662085. doi: 10.1093.
    >> Share

  425. MOESTRUP KS, Reekie J, Zucco AG, Jensen TO, et al
    Readmissions, post-discharge mortality and sustained recovery among patients admitted to hospital with COVID-19.
    Clin Infect Dis. 2022 Aug 8. pii: 6658187. doi: 10.1093.
    >> Share

  426. FOPPIANO PALACIOS C, Tucker EW, Travassos MA
    COVID-19 burden among unaccompanied minors in United States custody.
    Clin Infect Dis. 2022 Aug 5. pii: 6656047. doi: 10.1093.
    >> Share

  427. AWASTHI M, Golding H, Khurana S
    SARS-CoV-2 hyperimmune intravenous human immunoglobulins neutralizes Omicron subvariants BA.1, BA.2, BA.2.12.1, BA.3 and BA.4/BA.5 for treatment of COVID-19.
    Clin Infect Dis. 2022 Aug 4. pii: 6655744. doi: 10.1093.
    >> Share

  428. KLEYNHANS J, Walaza S, Martinson NA, Neti M, et al
    Household transmission of SARS-CoV-2 from adult index cases living with and without HIV in South Africa, 2020-2021: a case-ascertained, prospective observational household transmission study.
    Clin Infect Dis. 2022 Aug 4. pii: 6655792. doi: 10.1093.
    >> Share

  429. ZAMBRANO LD, Newhams MM, Olson SM, Halasa NB, et al
    BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years.
    Clin Infect Dis. 2022 Aug 4. pii: 6655523. doi: 10.1093.
    >> Share

  430. PRAY IW, Grajewski B, Morris C, Modji K, et al
    Measuring work-related risk of COVID-19: comparison of COVID-19 incidence by occupation and industry - Wisconsin, September 2020-May 2021.
    Clin Infect Dis. 2022 Aug 4. pii: 6655522. doi: 10.1093.
    >> Share

  431. ARASHIRO T, Arima Y, Muraoka H, Sato A, et al
    COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection during Delta-dominant and Omicron-dominant periods in Japan: a multi-center prospective case-control study (FASCINATE study).
    Clin Infect Dis. 2022 Aug 3. pii: 6653543. doi: 10.1093.
    >> Share

  432. VIHTA KD, Pouwels KB, Peto TE, Pritchard E, et al
    Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom.
    Clin Infect Dis. 2022 Aug 3. pii: 6653436. doi: 10.1093.
    >> Share

  433. KRISHNA BA, Metaxaki M, Wills MR, Sithole N, et al
    Reduced incidence of Long COVID referrals to the Cambridge University Teaching Hospital Long COVID clinic.
    Clin Infect Dis. 2022 Aug 1. pii: 6652885. doi: 10.1093.
    >> Share

  434. ATCHISON CJ, Moshe M, Brown JC, Whitaker M, et al
    Validity of self-testing at home with rapid SARS-CoV-2 antibody detection by lateral flow immunoassay.
    Clin Infect Dis. 2022 Aug 1. pii: 6652878. doi: 10.1093.
    >> Share

    July 2022
  435. MONTEJANO R, de la Calle-Prieto F, Velasco M, Guijarro C, et al
    Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe COVID-19: The PANCOVID Randomized Clinical Trial.
    Clin Infect Dis. 2022 Jul 30. pii: 6652179. doi: 10.1093.
    >> Share

  436. SINE K, Appaneal H, Dosa D, LaPlante KL, et al
    Antimicrobial Prescribing in the Telehealth Setting: Framework for stewardship during a period of rapid acceleration within primary care.
    Clin Infect Dis. 2022 Jul 30. pii: 6652160. doi: 10.1093.
    >> Share

  437. KERTES J, David SSB, Engel-Zohar N, Rosen K, et al
    Association between AZD7442 (tixagevimab-cilgavimab) administration and SARS-CoV-2 infection, hospitalization and mortality.
    Clin Infect Dis. 2022 Jul 29. pii: 6651663. doi: 10.1093.
    >> Share

  438. MARTINEZ-SANZ J, Serrano-Villar S, Muriel A, Fraile LJG, et al
    Metabolic-related outcomes after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in adults with HIV: a multicenter prospective cohort study.
    Clin Infect Dis. 2022 Jul 29. pii: 6651472. doi: 10.1093.
    >> Share

  439. LEHRNBECHER T, Sack U, Speckmann C, Groll AH, et al
    Longitudinal Immune Response to Three Doses of mRNA Vaccine Against COVID-19 in Pediatric Patients Receiving Chemotherapy for Cancer.
    Clin Infect Dis. 2022 Jul 28. pii: 6651274. doi: 10.1093.
    >> Share

  440. LI H, Gao M, You H, Zhang P, et al
    Association of nirmatrelvir/ritonavir treatment on upper respiratory SARS-CoV-2 RT-PCR negative conversion rates among high-risk patients with COVID-19.
    Clin Infect Dis. 2022 Jul 23. pii: 6649232. doi: 10.1093.
    >> Share

  441. ESPARCIA-PINEDO L, Yarci-Carrion A, Mateo-Jimenez G, Ropero N, et al
    Development of an effective immune response in adults with Down Syndrome after SARS-CoV-2 vaccination.
    Clin Infect Dis. 2022 Jul 23. pii: 6649074. doi: 10.1093.
    >> Share

  442. MALAHE SRK, Hoek RAS, Dalm VASH, Broers AEC, et al
    Clinical characteristics and outcome of immunocompromised patients with COVID-19 caused by the Omicron variant: a prospective observational study.
    Clin Infect Dis. 2022 Jul 23. pii: 6649068. doi: 10.1093.
    >> Share

  443. HUYGENS S, Munnink BO, Gharbharan A, Koopmans M, et al
    Sotrovimab resistance and viral persistence after treatment of immunocompromised patients infected with the SARS-CoV-2 Omicron variant.
    Clin Infect Dis. 2022 Jul 22. pii: 6648554. doi: 10.1093.
    >> Share

  444. ROTHBERG MB, Kim P, Shrestha NK, Kojima L, et al
    Protection Against the Omicron Variant Offered by Previous SARS-CoV-2 Infection: A Retrospective Cohort Study.
    Clin Infect Dis. 2022 Jul 22. pii: 6648553. doi: 10.1093.
    >> Share

  445. SAHNI LC, Naioti EA, Olson SM, Campbell AP, et al
    Sustained within-season vaccine effectiveness against influenza-associated hospitalization in children: Evidence from the New Vaccine Surveillance Network, 2015-2016 through 2019-2020.
    Clin Infect Dis. 2022 Jul 22. pii: 6648556. doi: 10.1093.
    >> Share

  446. HATFIELD KM, Baggs J, Wolford H, Fang M, et al
    Effectiveness of COVID-19 vaccination against SARS-CoV-2 Infection among Residents of US Nursing Homes, Before and During the Delta variant Predominance, December 2020 - November 2021.
    Clin Infect Dis. 2022 Jul 20. pii: 6646955. doi: 10.1093.
    >> Share

  447. VIEL KR
    Response to 'Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome'.
    Clin Infect Dis. 2022 Jul 12. pii: 6640218. doi: 10.1093.
    >> Share

  448. HUNYADY P, Streller L, Ruther DF, Groba SR, et al
    Secondary sclerosing cholangitis following COVID-19 disease: a multicenter retrospective study.
    Clin Infect Dis. 2022 Jul 9. pii: 6637421. doi: 10.1093.
    >> Share

  449. MIGUERES M, Dimeglio C, Mansuy JM, Abravanel F, et al
    The influence of the nasopharyngeal viral load on the spread of the Omicron BA.2 variant.
    Clin Infect Dis. 2022 Jul 7. pii: 6633281. doi: 10.1093.
    >> Share

  450. SANDERS JSF, Lianne Messchendorp A, de Vries RD, Baan CC, et al
    Antibody and T-cell responses 6 months after COVID-19 mRNA-1273 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant.
    Clin Infect Dis. 2022 Jul 7. pii: 6633280. doi: 10.1093.
    >> Share

  451. MAPONGA TG, Jeffries M, Tegally H, Sutherland A, et al
    Persistent SARS-CoV-2 infection with accumulation of mutations in a patient with poorly controlled HIV infection.
    Clin Infect Dis. 2022 Jul 6. pii: 6632801. doi: 10.1093.
    >> Share

  452. MURISON KR, Grima AA, Simmons AE, Tuite AR, et al
    Severity of SARS-CoV-2 Infection in Pregnancy in Ontario: A Matched Cohort Analysis.
    Clin Infect Dis. 2022 Jul 6. pii: 6632524. doi: 10.1093.
    >> Share

  453. DANIEL KELLY J, Lu S, Anglin K, Garcia-Knight M, et al
    Magnitude and determinants of SARS-CoV-2 household transmission: a longitudinal cohort study.
    Clin Infect Dis. 2022 Jul 5. pii: 6631204. doi: 10.1093.
    >> Share

  454. COHEN JM, Carter MJ, Ronny Cheung C, Ladhani S, et al
    Lower Risk of Multisystem Inflammatory Syndrome in Children (MIS-C) with the Delta and Omicron variants of SARS-CoV-2.
    Clin Infect Dis. 2022 Jul 5. pii: 6631205. doi: 10.1093.
    >> Share

  455. RIDOLFI F, Peetluk L, Amorim G, Turner M, et al
    TB TREATMENT OUTCOMES IN BRAZIL: DIFFERENT PREDICTORS FOR EACH TYPE OF UNSUCCESSFUL OUTCOME.
    Clin Infect Dis. 2022 Jul 5. pii: 6631480. doi: 10.1093.
    >> Share

  456. BAGGS J, Rose AN, McCarthy NL, Wolford H, et al
    Antibiotic Resistant Infections among COVID-19 Inpatients in U.S. Hospitals.
    Clin Infect Dis. 2022 Jul 2. pii: 6627591. doi: 10.1093.
    >> Share

  457. SAMSON ME, Still WL, Mark-Carew M, Jarris DK, et al
    Utility of a Test to Return Strategy to Identify Individuals with COVID-19 in the Pre-Kindergarten through Grade 12 School Setting - District of Columbia, January 2022.
    Clin Infect Dis. 2022 Jul 1. pii: 6625819. doi: 10.1093.
    >> Share

    June 2022
  458. GOOD MK, Czarnik M, Harmon KG, Aukerman D, et al
    SARS-CoV-2 Infections and Reinfections among Fully Vaccinated and Unvaccinated University Athletes - 15 States, January - November 2021.
    Clin Infect Dis. 2022 Jun 30. pii: 6623463. doi: 10.1093.
    >> Share

  459. MOORING EQ, Newell K, Castrodale L, Tompkins M, et al
    Increased Mortality among Persons with Symptomatic COVID-19 During the Period of SARS-CoV-2 B.1.617.2 (Delta Variant) Predominance-Alaska, November 2020-October 2021.
    Clin Infect Dis. 2022 Jun 29. pii: 6619623. doi: 10.1093.
    >> Share

  460. GLATMAN-FREEDMAN A, Feldman SF, Hershkovitz Y, Kaufman Z, et al
    Vaccine coverage associated with ending a SARS-CoV-2 wave: a retrospective longitudinal analysis.
    Clin Infect Dis. 2022 Jun 28. pii: 6619125. doi: 10.1093.
    >> Share

  461. TAM AR, Zhang RR, Lung KC, Liu R, et al
    Early treatment of high-risk hospitalized COVID-19 patients with a combination of interferon beta-1b and remdesivir: a phase 2 open-label randomized controlled trial.
    Clin Infect Dis. 2022 Jun 28. pii: 6619124. doi: 10.1093.
    >> Share

  462. MOLINE HL, Keaton A, Rice W, Varghese J, et al
    Effectiveness of COVID-19 mRNA vaccines against infection during an outbreak of SARS-CoV-2 Beta (B.1.351) variant in a skilled nursing facility - Virginia, March-April 2021.
    Clin Infect Dis. 2022 Jun 27. pii: 6618595. doi: 10.1093.
    >> Share

  463. IDOKO OT, Usuf E, Okomo U, Wonodi C, et al
    SARS-CoV-2 in Africa: current considerations and future projections.
    Clin Infect Dis. 2022 Jun 25. pii: 6617636. doi: 10.1093.
    >> Share

  464. OH DY, Holzer M, Paraskevopoulou S, Trofimova M, et al
    Advancing Precision Vaccinology by Molecular and Genomic Surveillance of SARS-CoV-2 in Germany, 2021.
    Clin Infect Dis. 2022 Jun 25. pii: 6617635. doi: 10.1093.
    >> Share

  465. BORAH BF, Pringle J, Flaherty M, Oeltmann JE, et al
    High Community Transmission of SARS-CoV-2 Associated with Decreased Contact Tracing Effectiveness for Identifying Persons at Elevated Risk of Infection - Vermont.
    Clin Infect Dis. 2022 Jun 24. pii: 6617336. doi: 10.1093.
    >> Share

  466. ARNALDO P, Mabunda N, Young PW, Tran T, et al
    Prevalence of SARS-CoV-2 antibodies in the Mozambican population: a cross-sectional Serologic study in three cities, July-August 2020.
    Clin Infect Dis. 2022 Jun 24. pii: 6617331. doi: 10.1093.
    >> Share

  467. KUTTY PK, Stuckey MJ, Koumans EH
    Vaccines, Variants, and Vigilance: Strengthening the COVID-19 Public Health Response through Partnerships and Collaborations.
    Clin Infect Dis. 2022 Jun 24. pii: 6617337. doi: 10.1093.
    >> Share

  468. CHOI D, Nielsen J, Waller LA, Patel SA, et al
    The US COVID-19 surveillance environment: An ecological analysis of the relationship of testing adequacy in the context of vaccination.
    Clin Infect Dis. 2022 Jun 24. pii: 6617111. doi: 10.1093.
    >> Share

  469. MORROCCHI E, Pighi C, Pascucci GR, Cotugno N, et al
    Perinatally HIV-infected adolescents and young adults demonstrate distinct BNT162b2 mRNA COVID-19 vaccine immunogenicity.
    Clin Infect Dis. 2022 Jun 23. pii: 6615389. doi: 10.1093.
    >> Share

  470. OHLSEN EC, Yankey D, Pezzi C, Kriss JL, et al
    COVID-19 vaccination coverage, intentions, attitudes and barriers by race/ethnicity, language of interview, and nativity, National Immunization Survey Adult COVID Module, April 22, 2021-January 29, 2022.
    Clin Infect Dis. 2022 Jun 23. pii: 6614630. doi: 10.1093.
    >> Share

  471. BOUTON TC, Atarere J, Turcinovic J, Seitz S, et al
    Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study.
    Clin Infect Dis. 2022 Jun 23. pii: 6614634. doi: 10.1093.
    >> Share

  472. BOUCAU J, Uddin R, Marino C, Regan J, et al
    Characterization of virologic rebound following nirmatrelvir-ritonavir treatment for COVID-19.
    Clin Infect Dis. 2022 Jun 23. pii: 6614635. doi: 10.1093.
    >> Share

  473. TEMTE JL, Barlow S, Temte E, Goss M, et al
    SARS-CoV-2 co-detection with influenza A and other respiratory viruses among school-aged children and their household members- March 12, 2020, to February 22, 2022, Dane County, Wisconsin.
    Clin Infect Dis. 2022 Jun 23. pii: 6614626. doi: 10.1093.
    >> Share

  474. LEVY R, Cohen R, Lev-Shalem L, Eisenkraft A, et al
    A Retrospective Database Analysis of Before and After Social Distancing in Relation to Pediatric Infection Rate and Healthcare Services Usage During the COVID-19 Pandemic.
    Clin Infect Dis. 2022 Jun 20. pii: 6611849. doi: 10.1093.
    >> Share

  475. BROSH-NISSIMOV T, Hussein K, Wiener-Well Y, Orenbuch-Harroch E, et al
    Hospitalized patients with severe COVID-19 during the Omicron wave in Israel - benefits of a fourth vaccine dose.
    Clin Infect Dis. 2022 Jun 20. pii: 6611845. doi: 10.1093.
    >> Share

  476. ZIPFEL CM, Paul P, Gowler CD, Reddy SC, et al
    Modeling the effectiveness of healthcare personnel reactive testing and screening for the SARS-CoV-2 Omicron variant within nursing homes.
    Clin Infect Dis. 2022 Jun 20. pii: 6611848. doi: 10.1093.
    >> Share

  477. STARGEL A, Taylor MM, Zansky S, Spencer K, et al
    Case Investigation and Contact Tracing Efforts from Health Departments in the United States, November 2020-December 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611688. doi: 10.1093.
    >> Share

  478. CARLIN AF, Clark AE, Chaillon A, Garretson AF, et al
    Virologic and Immunologic Characterization of COVID-19 Recrudescence after Nirmatrelvir/Ritonavir Treatment.
    Clin Infect Dis. 2022 Jun 20. pii: 6611663. doi: 10.1093.
    >> Share

  479. ROSKOSKY M, Moni G, Kawakami V, Lambert J, et al
    SARS-CoV-2 Transmission Associated with an Indoor Music Event That Required Proof of Full Vaccination Against COVID-19 Prior to Entry-Seattle, July 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611550. doi: 10.1093.
    >> Share

  480. SABLEROLLES RSG, Rietdijk WJR, Goorhuis A, Postma DF, et al
    Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers.
    Clin Infect Dis. 2022 Jun 20. pii: 6611568. doi: 10.1093.
    >> Share

  481. VU DM, Vu DTB, Do TTT, Olmsted AE, et al
    Presence of SARS-CoV-2 Antibodies among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 Vaccine.
    Clin Infect Dis. 2022 Jun 20. pii: 6611567. doi: 10.1093.
    >> Share

  482. KEATING P, Sell J, Chen J, Ackelsberg J, et al
    Delayed Recognition of COVID-19 in New York City: A descriptive analysis of COVID-19 illness prior to February 29, 2020.
    Clin Infect Dis. 2022 Jun 20. pii: 6611571. doi: 10.1093.
    >> Share

  483. KLAASSEN F, Chitwood MH, Cohen T, Pitzer VE, et al
    Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611479. doi: 10.1093.
    >> Share

  484. GOLD JAW, Ahmad FB, Cisewski JA, Rossen LM, et al
    Increased deaths from fungal infections during the COVID-19 pandemic-National Vital Statistics System, United States, January 2020-December 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611491. doi: 10.1093.
    >> Share

  485. CZECH-SIOLI M, Gunther T, Robitaille A, Roggenkamp H, et al
    Integration of sequencing and epidemiological data for surveillance of SARS-CoV-2 infections in a tertiary-care hospital.
    Clin Infect Dis. 2022 Jun 19. pii: 6611489. doi: 10.1093.
    >> Share

  486. STRID P, Zapata LB, Tong VT, Zambrano LD, et al
    COVID-19 Severity among Women of Reproductive Age with Symptomatic Laboratory-Confirmed SARS-CoV-2 by Pregnancy Status - United States, Jan 1, 2020 - Dec 25, 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611488. doi: 10.1093.
    >> Share

  487. RICHARDSON VL, Franco MAC, Marquez AB, Valdez LM, et al
    Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare workers - Mexico, March-December 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611492. doi: 10.1093.
    >> Share

  488. HALASA NB, Spieker AJ, Young CC, Olson SM, et al
    Life-Threatening Complications of Influenza versus COVID-19 in U.S. Children.
    Clin Infect Dis. 2022 Jun 19. pii: 6611483. doi: 10.1093.
    >> Share

  489. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Vorontsov O, et al
    Kinetics of maternally-derived anti- SARS-CoV-2 antibodies in infants in relation to the timing of antenatal vaccination.
    Clin Infect Dis. 2022 Jun 19. pii: 6611486. doi: 10.1093.
    >> Share

  490. FREE H, Luckhaupt SE, Billock RM, Groenewold MR, et al
    Reported exposures among in-person workers with SARS-CoV-2 infection in 6 states, September 2020-June 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611490. doi: 10.1093.
    >> Share

  491. TONG SYC, Mora J, Bowen AC, Cheng MP, et al
    The Staphylococcus aureus Network Adaptive Platform Trial protocol: New tools for an old foe.
    Clin Infect Dis. 2022 Jun 19. pii: 6611482. doi: 10.1093.
    >> Share

  492. RANGANATH N, O'Horo JC, Challener DW, Tulledge-Scheitel SM, et al
    Rebound Phenomenon after Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease-2019 in High-Risk Persons.
    Clin Infect Dis. 2022 Jun 14. pii: 6607746. doi: 10.1093.
    >> Share

  493. MONGE S, Rojas-Benedicto A, Olmedo C, Martin-Merino E, et al
    Effectiveness of a second dose of an mRNA vaccine against SARS-CoV-2 Omicron infection in individuals previously infected by other variants.
    Clin Infect Dis. 2022 Jun 10. pii: 6605647. doi: 10.1093.
    >> Share

  494. WEGRZYN RD, Appiah GD, Morfino R, Milford SR, et al
    Early detection of SARS-CoV-2 variants using traveler-based genomic surveillance at four US airports, September 2021- January 2022.
    Clin Infect Dis. 2022 Jun 10. pii: 6605116. doi: 10.1093.
    >> Share

  495. LIND ML, Schultes OL, Robertson AJ, Houde AJ, et al
    Testing Frequency Matters | An Evaluation of the Diagnostic Performance of a SARS-CoV-2 Rapid Antigen Test in United States Correctional Facilities.
    Clin Infect Dis. 2022 Jun 10. pii: 6605088. doi: 10.1093.
    >> Share

  496. LIM SY, Park S, Kim JY, Kim S, et al
    Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural SARS-CoV-2 Infection (With/Without subsequent COVID-19 Vaccination) Versus 2-dose COVID-19 Vaccination.
    Clin Infect Dis. 2022 Jun 10. pii: 6605068. doi: 10.1093.
    >> Share

  497. RUHLAND A, Fell A, Holzbauer SM, D'Heilly P, et al
    Exposure Outcomes in Fully Vaccinated Healthcare Personnel with Known SARS-CoV-2 Exposure-Minnesota, January-August 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605065. doi: 10.1093.
    >> Share

  498. MILLER MJ, Himschoot A, Fitch N, Jawalkar S, et al
    Association of Trends in SARS-CoV-2 Seroprevalence and State-Issued Nonpharmaceutical Interventions- United States, August 1, 2020 - March 30, 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605073. doi: 10.1093.
    >> Share

  499. BUSCH MP, Stramer SL, Stone M, Yu EA, et al
    Population-weighted seroprevalence from SARS-CoV-2 infection, vaccination, and hybrid immunity among U.S. blood donations from January-December 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605072. doi: 10.1093.
    >> Share

  500. LI ZN, Liu F, Jefferson S, Horner L, et al
    Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza.
    Clin Infect Dis. 2022 Jun 10. pii: 6605070. doi: 10.1093.
    >> Share

  501. MILLER AD, Yousaf AR, Bornstein E, Wu MJ, et al
    Multisystem Inflammatory Syndrome in Children (MIS-C) During SARS-CoV-2 Delta and Omicron Variant Circulation- United States, July 2021 - January 2022.
    Clin Infect Dis. 2022 Jun 10. pii: 6605071. doi: 10.1093.
    >> Share

  502. TOP KA, Chen RT, Levy O, Ozonoff A, et al
    Advancing the Science of Vaccine Safety during the COVID-19 Pandemic and Beyond: Launching an International Network of Special Immunization Services.
    Clin Infect Dis. 2022 Jun 9. pii: 6605049. doi: 10.1093.
    >> Share

  503. WAN EYF, Chui CSL, Ng VWS, Wang Y, et al
    mRNA (BNT162b2) COVID-19 vaccination increased risk of Bell's palsy: a nested case control and self-controlled case series study.
    Clin Infect Dis. 2022 Jun 8. pii: 6604461. doi: 10.1093.
    >> Share

  504. BART SM, Curtiss CC, Earnest R, Lobe-Costonis R, et al
    SARS-CoV-2 Outbreak at a College with High COVID-19 Vaccination Coverage-Connecticut, August-September 2021.
    Clin Infect Dis. 2022 Jun 8. pii: 6604453. doi: 10.1093.
    >> Share

  505. LEWIS NM, Self WH, Gaglani M, Ginde AA, et al
    Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
    Clin Infect Dis. 2022 Jun 8. pii: 6604454. doi: 10.1093.
    >> Share

  506. LEUNG NHL, Cheng SMS, Martin-Sanchez M, Au NYM, et al
    Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron variant in adults who received two doses of inactivated vaccine.
    Clin Infect Dis. 2022 Jun 8. pii: 6604400. doi: 10.1093.
    >> Share

  507. DOYLE TJ, Kiros GE, Schmitt-Matzen EN, Propper R, et al
    Maternal and perinatal outcomes associated with SARS-CoV-2 infection during pregnancy, Florida, 2020-2021: A retrospective cohort study.
    Clin Infect Dis. 2022 Jun 8. pii: 6604396. doi: 10.1093.
    >> Share

  508. ALHABBAB RY, Algaissi A, Mahmoud AB, Alkayyal AA, et al
    MERS-CoV infection elicits long-lasting specific antibody, T and B cell immune responses in recovered individuals.
    Clin Infect Dis. 2022 Jun 8. pii: 6604398. doi: 10.1093.
    >> Share

  509. NACHEGA JB, Sam-Agudu NA, Machekano RN, Rosenthal PJ, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis.
    Clin Infect Dis. 2022 Jun 8. pii: 6603567. doi: 10.1093.
    >> Share

  510. NACHEGA JB, Sam-Agudu NA, Siedner MJ, Rosenthal PJ, et al
    Prioritizing Pregnant Women for Coronavirus Disease 2019 Vaccination in African Countries.
    Clin Infect Dis. 2022 Jun 8. pii: 6603568. doi: 10.1093.
    >> Share

  511. STRAUS W, Urdaneta V, Esposito DB, Mansi JA, et al
    Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide.
    Clin Infect Dis. 2022 Jun 6. pii: 6603291. doi: 10.1093.
    >> Share

  512. RICHTERMAN A, Behrman A, Brennan PJ, O'Donnell JA, et al
    Durability of SARS-CoV-2 mRNA Booster Vaccine Protection Against Omicron Among Health Care Workers with a Vaccine Mandate.
    Clin Infect Dis. 2022 Jun 6. pii: 6603294. doi: 10.1093.
    >> Share

  513. LIN Y, Yue S, Yang Y, Yang S, et al
    Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern (VOCs): A Small-scale Clinical Trial.
    Clin Infect Dis. 2022 Jun 6. pii: 6603292. doi: 10.1093.
    >> Share

  514. NAJJAR-DEBBINY R, Gronich N, Weber G, Khoury J, et al
    Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients.
    Clin Infect Dis. 2022 Jun 2. pii: 6599020. doi: 10.1093.
    >> Share

    May 2022
  515. MARRA AR, Miraglia JL, Malheiros DT, Guozhang Y, et al
    Effectiveness of heterologous COVID-19 vaccine booster dosing in Brazilian healthcare workers, 2021.
    Clin Infect Dis. 2022 May 27. pii: 6594056. doi: 10.1093.
    >> Share

  516. NASH D, Rane MS, Robertson MM, Chang M, et al
    SARS-CoV-2 incidence and risk factors in a national, community-based prospective cohort of U.S. adults.
    Clin Infect Dis. 2022 May 27. pii: 6594058. doi: 10.1093.
    >> Share

  517. ZHAO M, Slotkin R, Sheth AH, Pischel L, et al
    Serum Neutralizing Antibody Titers 12 months after COVID-19 mRNA Vaccination: Correlation to Clinical Variables in an Adult, US-Population.
    Clin Infect Dis. 2022 May 26. pii: 6593314. doi: 10.1093.
    >> Share

  518. PETROS BA, Turcinovic J, Welch NL, White LF, et al
    Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations.
    Clin Infect Dis. 2022 May 25. pii: 6591846. doi: 10.1093.
    >> Share

  519. GRIMA AA, Murison KR, Simmons AE, Tuite AR, et al
    Relative Virulence of SARS-CoV-2 Among Vaccinated and Unvaccinated Individuals Hospitalized with SARS-CoV-2.
    Clin Infect Dis. 2022 May 25. pii: 6591845. doi: 10.1093.
    >> Share

  520. RIDDELL AC, Kele B, Harris K, Bible J, et al
    Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease.
    Clin Infect Dis. 2022 May 25. pii: 6591841. doi: 10.1093.
    >> Share


  521. Correction to: Investigation of a Suspect Severe Acute Respiratory Syndrome Coronavirus-2 and Influenza A Mixed Outbreak: Lessons Learned for Long-Term Care Facilities Nationwide.
    Clin Infect Dis. 2022 May 24. pii: 6591404. doi: 10.1093.
    >> Share


  522. Correction to: Clinical Experience With Severe Acute Respiratory Syndrome Coronavirus 2-Related Illness in Children: Hospital Experience in Cape Town, South Africa.
    Clin Infect Dis. 2022 May 24. pii: 6591403. doi: 10.1093.
    >> Share

  523. EPSI NJ, Richard SA, Lindholm DA, Mende K, et al
    Understanding 'hybrid immunity': comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines.
    Clin Infect Dis. 2022 May 24. pii: 6591282. doi: 10.1093.
    >> Share

  524. KIM DY, Lin MY, Jennings C, Li H, et al
    Duration of replication-competent SARS-CoV-2 shedding among patients with severe or critical coronavirus disease 2019 (COVID-19).
    Clin Infect Dis. 2022 May 24. pii: 6590994. doi: 10.1093.
    >> Share

  525. CORRADINI P, Agrati C, Apolone G, Mantovani A, et al
    Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study.
    Clin Infect Dis. 2022 May 24. pii: 6590993. doi: 10.1093.
    >> Share

  526. LOFGREN E, Naumova EN, Gorski J, Naumov Y, et al
    How drivers of seasonality in respiratory infections may impact vaccine strategy: a case study in how COVID-19 may help us solve one of influenza's biggest challenges.
    Clin Infect Dis. 2022 May 24. pii: 6590989. doi: 10.1093.
    >> Share

  527. EYAL N, Gheaus A, Gosseries A, Magalhaes M, et al
    COVID vaccine prioritization in low- and middle-income countries may justifiably depart from high-income countries' age priorities.
    Clin Infect Dis. 2022 May 24. pii: 6590988. doi: 10.1093.
    >> Share

  528. LAGOUSI T, Papadatou I, Strempas P, Chatzikalil E, et al
    PAVING THE WAY TOWARDS PRECISION VACCINOLOGY: THE PARADIGM OF MYOCARDITIS AFTER COVID-19 VACCINATION.
    Clin Infect Dis. 2022 May 24. pii: 6590985. doi: 10.1093.
    >> Share

  529. SHAPIRO JR, Sitaras I, Park HS, Aytenfisu TY, et al
    Association of frailty, age, and biological sex with SARS-CoV-2 mRNA vaccine-induced immunity in older adults.
    Clin Infect Dis. 2022 May 24. pii: 6590987. doi: 10.1093.
    >> Share

  530. ROTTENSTREICH A, Vorontsov O, Alfi O, Zarbiv G, et al
    Maternal and Neonatal SARS-CoV-2 Omicron Variant Neutralization after Antenatal mRNA Vaccination.
    Clin Infect Dis. 2022 May 24. pii: 6590984. doi: 10.1093.
    >> Share

  531. DELAHOY MJ, Ujamaa D, Taylor CA, Cummings C, et al
    Comparison of influenza and COVID-19-associated hospitalizations among children < 18 years old in the United States-FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021).
    Clin Infect Dis. 2022 May 20. pii: 6589788. doi: 10.1093.
    >> Share

  532. LEVIN-RECTOR A, Firestein L, McGibbon E, Sell J, et al
    Reduced Odds of SARS-CoV-2 Reinfection after Vaccination among New York City Adults, July-November 2021.
    Clin Infect Dis. 2022 May 20. pii: 6589783. doi: 10.1093.
    >> Share

  533. TENFORDE MW, Self WH, Zhu Y, Naioti EA, et al
    Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States.
    Clin Infect Dis. 2022 May 17. pii: 6587132. doi: 10.1093.
    >> Share

  534. MARTINUZZI E, Benzaquen J, Guerin O, Leroy S, et al
    A Single Dose of BNT162b2 mRNA Vaccine Induces Airway Immunity in SARS-CoV-2 Naive and recovered COVID-19 subjects.
    Clin Infect Dis. 2022 May 17. pii: 6586846. doi: 10.1093.
    >> Share

  535. SHOHAM S, Bloch EM, Casadevall A, Hanley D, et al
    Transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection: a double-blinded, phase 2 randomized, controlled trial.
    Clin Infect Dis. 2022 May 17. pii: 6586841. doi: 10.1093.
    >> Share

  536. WEITZMAN ER, Kossowsky J, Blakemore LM, Cox R, et al
    Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making.
    Clin Infect Dis. 2022 May 17. pii: 6586840. doi: 10.1093.
    >> Share

  537. ODUMADE OA, van Haren SD, Angelidou A
    Implications of the SARS-CoV-2 pandemic on the epidemiology of pediatric Respiratory Syncytial Virus (RSV) infection.
    Clin Infect Dis. 2022 May 17. pii: 6586842. doi: 10.1093.
    >> Share

  538. WEITZMAN ER, Sherman AC, Levy O
    Pediatric SARS-CoV-2 Vaccines: Perceptions and Attitudes from the FDA Public Commentary.
    Clin Infect Dis. 2022 May 17. pii: 6586838. doi: 10.1093.
    >> Share

  539. COLE KA, Zhou AY, Jones T, Moore WJ, et al
    How to Harness the Power of Social Media for Quality Drug Information in Infectious Diseases: Perspectives on Behalf of the Society of Infectious Diseases Pharmacists.
    Clin Infect Dis. 2022;74.
    >> Share

  540. NEMATOLLAHI S, Minter DJ, Barlow B, Nolan NS, et al
    The Digital Classroom: How to Leverage Social Media for Infectious Diseases Education.
    Clin Infect Dis. 2022;74.
    >> Share

  541. SCHWARTZ IS, McCarty T, Woc-Colburn LE, Titanji BK, et al
    Educational Impact of #IDJClub, a Twitter-Based Infectious Diseases Journal Club.
    Clin Infect Dis. 2022;74.
    >> Share

  542. BARI A, Heymann M, Cohen RJ, Zhao R, et al
    Exploring Coronavirus Disease 2019 Vaccine Hesitancy on Twitter Using Sentiment Analysis and Natural Language Processing Algorithms.
    Clin Infect Dis. 2022;74.
    >> Share

  543. ZENG C, Zhang J, Li Z, Sun X, et al
    Population Mobility and Aging Accelerate the Transmission of Coronavirus Disease 2019 in the Deep South: A County-Level Longitudinal Analysis.
    Clin Infect Dis. 2022;74.
    >> Share

  544. DESAI AN, Ruidera D, Steinbrink JM, Granwehr B, et al
    Misinformation and Disinformation: The Potential Disadvantages of Social Media in Infectious Disease and How to Combat Them.
    Clin Infect Dis. 2022;74.
    >> Share

  545. POH XY, Tan CW, Lee IR, Chavatte JM, et al
    Antibody response of heterologous vs homologous mRNA vaccine boosters against the SARS-CoV-2 Omicron variant: interim results from the PRIBIVAC study, A Randomized Clinical Trial.
    Clin Infect Dis. 2022 May 11. pii: 6583615. doi: 10.1093.
    >> Share

  546. DE CASTILHOS J, Zamir E, Hippchen T, Rohrbach R, et al
    Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients.
    Clin Infect Dis. 2022 May 10. pii: 6583345. doi: 10.1093.
    >> Share

  547. CONTI MG, Terreri S, Terrin G, Natale F, et al
    SARS-CoV-2 infection versus vaccination in pregnancy: Implications for maternal and infant immunity.
    Clin Infect Dis. 2022 May 10. pii: 6583148. doi: 10.1093.
    >> Share

  548. MOISAN A, Mastrovito B, De Oliveira F, Martel M, et al
    Evidence of transmission and circulation of Deltacron XD recombinant SARS-CoV-2 in Northwest France.
    Clin Infect Dis. 2022 May 10. pii: 6583149. doi: 10.1093.
    >> Share

  549. SPARKE M, Levy O
    Competing responses to global inequalities in access to COVID vaccines: Vaccine Diplomacy and Vaccine Charity Versus Vaccine Liberty.
    Clin Infect Dis. 2022 May 10. pii: 6583150. doi: 10.1093.
    >> Share

  550. ZURCHER K, Abela IA, Stange M, Dupont C, et al
    Alpha variant coronavirus outbreak in a nursing home despite high vaccination coverage: molecular, epidemiological and immunological studies.
    Clin Infect Dis. 2022 May 6. pii: 6582009. doi: 10.1093/cid/ciab1005.
    >> Share

  551. DALAI SC, Dines JN, Snyder TM, Gittelman RM, et al
    Clinical Validation of a Novel T-cell Receptor Sequencing Assay for Identification of Recent or Prior SARS-CoV-2 Infection.
    Clin Infect Dis. 2022 May 6. pii: 6581622. doi: 10.1093.
    >> Share

  552. DOWLING DJ, Levy O
    A Precision Adjuvant Approach to Enhance SARS-CoV-2 Vaccines Optimized for Immunologically Distinct Vulnerable Populations.
    Clin Infect Dis. 2022 May 4. pii: 6580093. doi: 10.1093.
    >> Share

  553. LASSER J, Hell T, Garcia D
    Assessment of the effectiveness of Omicron transmission mitigation strategies for European universities using an agent-based network model.
    Clin Infect Dis. 2022 May 3. pii: 6577094. doi: 10.1093.
    >> Share

  554. BUTT AA, Talisa VB, Shaikh OS, Omer SB, et al
    Relative Vaccine Effectiveness of a SARS-CoV-2 mRNA Vaccine Booster Dose Against the Omicron Variant.
    Clin Infect Dis. 2022 May 3. pii: 6577096. doi: 10.1093.
    >> Share

  555. VERDERESE JP, Henry L, Younossi ZM
    Reply to Bailly et al.
    Clin Infect Dis. 2022;74:1707-1708.
    >> Share

    April 2022
  556. MILLER AD, Zambrano LD, Yousaf AR, Abrams JY, et al
    Correction to: Multisystem Inflammatory Syndrome in Children-United States, February 2020-July 2021.
    Clin Infect Dis. 2022 Apr 27. pii: 6574996. doi: 10.1093.
    >> Share

  557. ROSS JA, Malone PK, Levy S
    The Impact of the SARS-CoV-2 Pandemic on Substance Use in the US.
    Clin Infect Dis. 2022 Apr 27. pii: 6574792. doi: 10.1093.
    >> Share

  558. CADNUM JL, Jencson AL, Alhmidi H, Zabarsky TF, et al
    Airflow patterns in double occupancy patient rooms may contribute to roommate-to-roommate transmission of severe acute respiratory syndrome coronavirus 2.
    Clin Infect Dis. 2022 Apr 27. pii: 6574835. doi: 10.1093.
    >> Share

  559. SHRESTHA NK, Shrestha P, Burke PC, Nowacki AS, et al
    Coronavirus Disease 2019 (COVID-19) Vaccine Boosting in Previously Infected or Vaccinated Individuals.
    Clin Infect Dis. 2022 Apr 27. pii: 6574819. doi: 10.1093.
    >> Share

  560. CORVOL H, de Miranda S, Dehillotte C, Lemonnier L, et al
    Cumulative Incidence and Risk Factors for Severe COVID-19 in French People with Cystic Fibrosis.
    Clin Infect Dis. 2022 Apr 27. pii: 6574734. doi: 10.1093.
    >> Share

  561. SHARMA A, Oda G, Holodniy M
    Effectiveness of mRNA-based vaccines during the emergence of SARS-CoV-2 Omicron variant.
    Clin Infect Dis. 2022 Apr 27. pii: 6574744. doi: 10.1093.
    >> Share

  562. BUSKERMOLEN M, Molthof I, Voeten HA, van Twillert J, et al
    Vaccination did not prevent severe COVID in an outbreak among older residents of a nursing home, B.1.617.2 variant, July 2021.
    Clin Infect Dis. 2022 Apr 27. pii: 6574733. doi: 10.1093.
    >> Share

  563. BENFIELD T, Bodilsen J, Brieghel C, Harboe ZB, et al
    Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study.
    Clin Infect Dis. 2022 Apr 23. pii: 6572821. doi: 10.1093.
    >> Share

  564. GAYLIS NB, Ritter A, Kelly SA, Pourhassan NZ, et al
    Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome.
    Clin Infect Dis. 2022 Apr 22. pii: 6572226. doi: 10.1093.
    >> Share

  565. HOLUBAR M, Subramanian A, Purington N, Hedlin H, et al
    Favipiravir for treatment of outpatients with asymptomatic or uncomplicated COVID-19: a double-blind randomized, placebo-controlled, phase 2 trial.
    Clin Infect Dis. 2022 Apr 21. pii: 6572081. doi: 10.1093.
    >> Share

  566. SOLERA JT, Arbol BG, Alshahrani A, Bahinskaya I, et al
    Impact of Vaccination and Early Monoclonal Antibody Therapy on COVID-19 Outcomes in Organ Transplant Recipients During the Omicron Wave.
    Clin Infect Dis. 2022 Apr 21. pii: 6571785. doi: 10.1093.
    >> Share

  567. LIANG EN W, Ko KK, Conceicao EP, Aung MK, et al
    Enhanced infection-prevention measures including universal N95 usage and daily testing: the impact on SARS-CoV-2 transmission in cohorted hospital cubicles through successive Delta and Omicron waves.
    Clin Infect Dis. 2022 Apr 21. pii: 6571575. doi: 10.1093.
    >> Share

  568. ZAHRA FT, Grubbs G, Dummer K, Tremoulet AH, et al
    Neutralization of SARS-CoV-2 Omicron and other variants in serum from children with vaccination-induced myocarditis.
    Clin Infect Dis. 2022 Apr 21. pii: 6571576. doi: 10.1093.
    >> Share

  569. LONG SM, Chern A, Cooley V, Chung S, et al
    Temporal Dynamics of Nasopharyngeal and Tracheal SARS-CoV-2 Cycle Thresholds in COVID-19 Patients with Tracheostomy.
    Clin Infect Dis. 2022 Apr 20. pii: 6571468. doi: 10.1093.
    >> Share

  570. LOPEZ MONTESINOS I, Arrieta-Aldea I, Dicastillo A, Zuccarino F, et al
    Comparison of hospitalized COVID-19 and influenza patients requiring supplemental oxygen in a cohort study: clinical impact and resource consumption.
    Clin Infect Dis. 2022 Apr 20. pii: 6571459. doi: 10.1093.
    >> Share

  571. BONENFANT G, Deyoe J, Wong T, Grijalva CG, et al
    Surveillance and correlation of SARS-CoV-2 viral RNA, antigen, virus isolation, and self-reported symptoms in a longitudinal study with daily sampling.
    Clin Infect Dis. 2022 Apr 20. pii: 6571330. doi: 10.1093.
    >> Share

  572. MELGAR M, Haston J, DeCuir J, Cheng Q, et al
    Multisystem inflammatory syndrome in adults (MIS-A): case finding through systematic review of electronic medical records.
    Clin Infect Dis. 2022 Apr 20. pii: 6571412. doi: 10.1093.
    >> Share

  573. DAN J, da Silva Antunes R, Grifoni A, Weiskopf D, et al
    Observations and perspectives on adaptive immunity to SARS-CoV-2.
    Clin Infect Dis. 2022 Apr 20. pii: 6571103. doi: 10.1093.
    >> Share

  574. KIM J, Choe YJ, Jang EJ, Lim DS, et al
    Effectiveness of Booster mRNA Vaccines against SARS-CoV-2 Infection in Elderly Population, South Korea, October 2021 - January 2022.
    Clin Infect Dis. 2022 Apr 19. pii: 6570782. doi: 10.1093.
    >> Share

  575. NANISHI E, Angelidou A, Rotman C, Dowling DJ, et al
    Precision Vaccine Adjuvants for Older Adults: A Scoping Review.
    Clin Infect Dis. 2022 Apr 19. pii: 6570880. doi: 10.1093.
    >> Share

  576. LEVY O, Angelidou A, Idoko O, Lewis NP, et al
    Precision Vaccines: Lessons Learned from the Coronavirus Pandemic.
    Clin Infect Dis. 2022 Apr 19. pii: 6570826. doi: 10.1093.
    >> Share

  577. PLUMMER JT, Contreras D, Zhang W, Binek A, et al
    USA SARS-CoV-2 Epsilon Variant: Though Highly Transmissible has an Adjusted Muted Host T-Cell Response.
    Clin Infect Dis. 2022 Apr 19. pii: 6570676. doi: 10.1093.
    >> Share

  578. WOLDEMESKEL BA, Garliss CC, Aytenfisu TY, Johnston TS, et al
    Discordant antibody and T cell responses to the SARS-CoV-2 Omicron variant in COVID-19 mRNA vaccine recipient.
    Clin Infect Dis. 2022 Apr 19. pii: 6570698. doi: 10.1093.
    >> Share

  579. SKOWRONSKI DM, Febriani Y, Ouakki M, Setayeshgar S, et al
    Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada.
    Clin Infect Dis. 2022 Apr 19. pii: 6570607. doi: 10.1093.
    >> Share

  580. MAEDA H, Saito N, Igarashi A, Ishida M, et al
    Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the Delta variant epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS).
    Clin Infect Dis. 2022 Apr 19. pii: 6570603. doi: 10.1093.
    >> Share

  581. ALYSSA FITZPATRICK A, Cooper C, Vasilunas N, Ritchie B, et al
    Describing the impact of maternal hyperimmune globulin and valaciclovir on the outcomes of CMV infection in pregnancy: a systematic review.
    Clin Infect Dis. 2022 Apr 19. pii: 6570695. doi: 10.1093.
    >> Share

  582. SHERMAN AC, Rouphael N, Baden LR
    COVID-19 Vaccine Trials (and Tribulations): How to improve the process of clinical trials in a pandemic.
    Clin Infect Dis. 2022 Apr 18. pii: 6569988. doi: 10.1093.
    >> Share

  583. MASSO-SILVA JA, Moshensky A, Lam MTY, Odish M, et al
    Correction to: Increased Peripheral Blood Neutrophil Activation Phenotypes and Neutrophil Extracellular Trap Formation in Critically Ill Coronavirus Disease 2019 Patients: A Case Series and Review of the Literature.
    Clin Infect Dis. 2022 Apr 13. pii: 6568031. doi: 10.1093.
    >> Share

  584. DALE AP, Almendares O, Howard B, Burnett E, et al
    Investigation of A SARS-CoV-2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis - Maricopa County, Arizona, June-July 2021.
    Clin Infect Dis. 2022 Apr 12. pii: 6567536. doi: 10.1093.
    >> Share

  585. PREMIKHA M, Chiew CJ, Wei WE, Leo YS, et al
    Comparative Effectiveness of mRNA and Inactivated Whole Virus Vaccines against COVID-19 Infection and Severe Disease in Singapore.
    Clin Infect Dis. 2022 Apr 12. pii: 6567428. doi: 10.1093.
    >> Share

  586. PAREDES MI, Lunn SM, Famulare M, Frisbie LA, et al
    Associations between SARS-CoV-2 variants and risk of COVID-19 hospitalization among confirmed cases in Washington State: a retrospective cohort study.
    Clin Infect Dis. 2022 Apr 12. pii: 6567408. doi: 10.1093.
    >> Share

  587. MOLODTSOV IA, Kegeles E, Mitin AN, Mityaeva O, et al
    SARS-CoV-2-specific T cells and antibodies in COVID-19 protection: a prospective study.
    Clin Infect Dis. 2022 Apr 12. pii: 6567222. doi: 10.1093.
    >> Share

  588. TADESSE BT, Khanam F, Ahmed F, Im J, et al
    Prevention of typhoid by Vi conjugate vaccine and achievable improvements in household WASH: Evidence from a cluster-randomized trial in Dhaka, Bangladesh.
    Clin Infect Dis. 2022 Apr 12. pii: 6567455. doi: 10.1093.
    >> Share

  589. BUTT AA, Dargham SR, Loka S, Shaik RM, et al
    COVID-19 Disease Severity in Children Infected with the Omicron Variant.
    Clin Infect Dis. 2022 Apr 11. pii: 6566327. doi: 10.1093.
    >> Share

  590. SKEGGS J, MacPhail A, Korman T, Woolley I, et al
    Reductions in Antibiotic Prescribing in Australia During the SARS-CoV-2 Pandemic: National Prescribing Data.
    Clin Infect Dis. 2022 Apr 11. pii: 6566296. doi: 10.1093.
    >> Share

  591. MARGALIT I, Yelin D, Sagi M, Rahat MM, et al
    Risk factors and multidimensional assessment of long COVID fatigue: a nested case-control study.
    Clin Infect Dis. 2022 Apr 11. pii: 6566295. doi: 10.1093.
    >> Share

  592. RZYMSKI P, Falfushynska H, Fal A
    Vaccination of Ukrainian Refugees: Need for Urgent Action.
    Clin Infect Dis. 2022 Apr 11. pii: 6569707. doi: 10.1093.
    >> Share

  593. KUSEJKO K, Salazar-Vizcaya L, Shah C, Stockle M, et al
    Sustained effect on hepatitis C elimination among men who have sex with men in the Swiss HIV Cohort Study: A systematic re-screening for hepatitis C RNA two years following a nation-wide elimination program.
    Clin Infect Dis. 2022 Apr 11. pii: 6566325. doi: 10.1093.
    >> Share

  594. CAI J, Lin Y, Wu MJ
    Letter to editor regarding "Clinical Presentation and Outcomes of Pregnant Women With Coronavirus Disease 2019: A Systematic Review and Meta-analysis".
    Clin Infect Dis. 2022;74:1319.
    >> Share

  595. RASMUSSEN TA, Ahuja SK, Kuwanda L, Vjecha MJ, et al
    Antiretroviral initiation at >/=800 CD4+ cells/ mm 3 associated with lower HIV reservoir size.
    Clin Infect Dis. 2022 Apr 9. pii: 6565728. doi: 10.1093.
    >> Share

  596. KOLODZIEJ LM, van Lelyveld SFL, Haverkort ME, Mariman R, et al
    High SARS-CoV-2 household transmission rates detected by dense saliva sampling.
    Clin Infect Dis. 2022 Apr 6. pii: 6564312. doi: 10.1093.
    >> Share

  597. GAZIT S, Shlezinger R, Perez G, Lotan R, et al
    SARS-CoV-2 Naturally Acquired Immunity vs. Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: a Retrospective Cohort Study.
    Clin Infect Dis. 2022 Apr 5. pii: 6563799. doi: 10.1093.
    >> Share

  598. ANTINORI A, Cicalini S, Meschi S, Bordoni V, et al
    Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with current CD4 T-lymphocyte count.
    Clin Infect Dis. 2022 Apr 2. pii: 6562777. doi: 10.1093.
    >> Share

  599. PARK S, Lim SY, Kim JY, Park H, et al
    Clinical and virological characteristics of SARS-CoV-2 B.1.617.2 (Delta) variant: a prospective cohort study.
    Clin Infect Dis. 2022 Apr 1. pii: 6562005. doi: 10.1093.
    >> Share

    March 2022
  600. GARRETT N, Tapley A, Andriesen J, Seocharan I, et al
    High Asymptomatic Carriage with the Omicron Variant in South Africa.
    Clin Infect Dis. 2022 Mar 30. pii: 6556153. doi: 10.1093.
    >> Share

  601. TANDE AJ, Swift MD, Challener DW, Berbari EF, et al
    Utility of Follow-up COVID-19 Antigen Tests After Acute SARS-CoV-2 Infection Among Healthcare Personnel.
    Clin Infect Dis. 2022 Mar 30. pii: 6555774. doi: 10.1093.
    >> Share

  602. NATHAVITHARANA RR, Mishra H, Sullivan A, Hurwitz S, et al
    Predicting airborne infection risk: Association between personal ambient carbon dioxide level monitoring and incidence of tuberculosis infection in South African health workers.
    Clin Infect Dis. 2022 Mar 26. pii: 6554598. doi: 10.1093.
    >> Share

  603. DOLL MK, Pettigrew SM, Ma J, Verma A, et al
    Effects of Confounding Bias in COVID-19 and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors.
    Clin Infect Dis. 2022 Mar 24. pii: 6553950. doi: 10.1093.
    >> Share

  604. HERNANDEZ AV, Roman YM, Burela PA, Pasupuleti V, et al
    Reply to Banno et al and Padhi et al.
    Clin Infect Dis. 2022;74:1122-1123.
    >> Share

  605. NG OT, Koh V, Chiew CJ, Marimuthu K, et al
    Impact of SARS-CoV-2 Vaccination and Paediatric Age on Delta Variant Household Transmission.
    Clin Infect Dis. 2022 Mar 22. pii: 6551710. doi: 10.1093.
    >> Share

  606. CHANDNA A, Mahajan R, Gautam P, Mwandigha L, et al
    Facilitating safe discharge through predicting disease progression in moderate COVID-19: a prospective cohort study to develop and validate a clinical prediction model in resource-limited settings.
    Clin Infect Dis. 2022 Mar 21. pii: 6551704. doi: 10.1093.
    >> Share

  607. GIMENEZ E, Albert E, Zulaica J, Torres I, et al
    SARS-CoV-2 adaptive immunity in nursing home residents following a third dose of the Comirnaty(R) COVID-19 vaccine.
    Clin Infect Dis. 2022 Mar 21. pii: 6551700. doi: 10.1093.
    >> Share


  608. Erratum to: Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa.
    Clin Infect Dis. 2022 Mar 17. pii: 6549865. doi: 10.1093.
    >> Share

  609. EDELSTEIN M, Beiruti KW, Ben-Amram H, Bar-Zeev N, et al
    Antibody-mediated Immunogenicity against SARS-CoV-2 following priming, boosting and hybrid immunity: insights from 11 months of follow-up of a healthcare worker cohort in Israel, December 2020-October 2021.
    Clin Infect Dis. 2022 Mar 12. pii: 6547893. doi: 10.1093.
    >> Share

  610. DOERNBERG SB, Holubar M, Jain V, Weng Y, et al
    Incidence and prevalence of COVID-19 within a healthcare worker cohort during the first year of the SARS-CoV-2 pandemic.
    Clin Infect Dis. 2022 Mar 12. pii: 6547892. doi: 10.1093.
    >> Share

  611. GALLAGHER KME, Leick MB, Larson RC, Berger TR, et al
    Differential T cell immunity to SARS-CoV-2 in mRNA-1273 and BNT162b2 vaccinated individuals.
    Clin Infect Dis. 2022 Mar 12. pii: 6547848. doi: 10.1093.
    >> Share

  612. ALSVED M, Nygren D, Thuresson S, Medstrand P, et al
    SARS-CoV-2 in exhaled aerosol particles from covid-19 cases and its association to household transmission.
    Clin Infect Dis. 2022 Mar 10. pii: 6546685. doi: 10.1093.
    >> Share

  613. FITZGERALD R, Dickinson L, Else L, Fletcher T, et al
    Pharmacokinetics of ss-d-N4-hydroxycytidine, the parent nucleoside of prodrug molnupiravir, in non-plasma compartments of patients with SARS-CoV-2 infection.
    Clin Infect Dis. 2022 Mar 10. pii: 6546684. doi: 10.1093.
    >> Share

  614. CHENG VC, Ip JD, Chu AW, Tam AR, et al
    Rapid spread of SARS-CoV-2 Omicron subvariant BA.2 in a single-source community outbreak.
    Clin Infect Dis. 2022 Mar 10. pii: 6546687. doi: 10.1093.
    >> Share

  615. RIFE MAGALIS B, Rich S, Tagliamonte MS, Mavian C, et al
    SARS-CoV-2 Delta vaccine breakthrough transmissibility in Alachua County, Florida.
    Clin Infect Dis. 2022 Mar 10. pii: 6546683. doi: 10.1093.
    >> Share

  616. WESTBROOK AL, Benedit LC, Frediani JK, Griffiths MA, et al
    Predictive value of isolated symptoms for diagnosis of SARS-CoV-2 infection in children tested during peak circulation of the delta variant.
    Clin Infect Dis. 2022 Mar 10. pii: 6546602. doi: 10.1093.
    >> Share

  617. WOLTER N, Tempia S, von Gottberg A, Bhiman JN, et al
    Seroprevalence of SARS-CoV-2 after the second wave in South Africa in HIV-infected and uninfected persons: a cross-sectional household survey.
    Clin Infect Dis. 2022 Mar 10. pii: 6546682. doi: 10.1093.
    >> Share

  618. LUSTIG Y, Mendelson E, Mandelboim M, Biber A, et al
    Existence of immunological memory response in true sero-negative individuals post COVID-19 molecular diagnosis.
    Clin Infect Dis. 2022 Mar 10. pii: 6546613. doi: 10.1093.
    >> Share

  619. YAU CH, Masuda Y, Ng QX, Teoh SE, et al
    Addressing the Elephant in the Room: Intravenous Injection of COVID-19 mRNA.
    Clin Infect Dis. 2022 Mar 9. pii: 6545850. doi: 10.1093.
    >> Share

  620. BALCELLS ME, Le Corre N, Duran J, Ceballos ME, et al
    Reduced immune response to inactivated SARS-CoV-2 vaccine in a cohort of immunocompromised patients in Chile.
    Clin Infect Dis. 2022 Mar 7. pii: 6543937. doi: 10.1093.
    >> Share

  621. SANDMANN FG, Tessier E, Lacy J, Kall M, et al
    Long-term health-related quality of life in non-hospitalised COVID-19 cases with confirmed SARS-CoV-2 infection in England: Longitudinal analysis and cross-sectional comparison with controls.
    Clin Infect Dis. 2022 Mar 5. pii: 6542727. doi: 10.1093.
    >> Share

  622. MOORLAG SJCFM, Taks E, Ten Doesschate T, van der Vaart TW, et al
    Efficacy of Bacillus Calmette-Guerin vaccination against respiratory tract infections in the elderly during the Covid-19 pandemic.
    Clin Infect Dis. 2022 Mar 5. pii: 6543010. doi: 10.1093.
    >> Share

  623. POLLOCK BD, Storlie CB, Tande AJ, Sampathkumar P, et al
    Real-world incidence of breakthrough COVID-19 hospitalization after vaccination versus natural infection in a large, local, empaneled primary care population using time-to-event analysis.
    Clin Infect Dis. 2022 Mar 5. pii: 6542971. doi: 10.1093.
    >> Share

  624. HURST JH, McCumber AW, Aquino JN, Rodriguez J, et al
    Age-related changes in the nasopharyngeal microbiome are associated with SARS-CoV-2 infection and symptoms among children, adolescents, and young adults.
    Clin Infect Dis. 2022 Mar 5. pii: 6542968. doi: 10.1093.
    >> Share

  625. SARAVOLATZ LD, Depcinski S, Sharma M
    Molnupiravir and Nirmatrelvir-Ritonavir: Oral COVID Antiviral Drugs.
    Clin Infect Dis. 2022 Mar 4. pii: 6542722. doi: 10.1093.
    >> Share

  626. BUTT AA, Talisa VB, Yan P, Shaikh OS, et al
    Vaccine Effectiveness of Three vs. Two Doses of SARS-CoV-2 mRNA Vaccines in a High Risk National Population.
    Clin Infect Dis. 2022 Mar 4. pii: 6542712. doi: 10.1093.
    >> Share

  627. SPINELLI MA, Le Tourneau N, Glidden DV, Hsu L, et al
    Impact of Multi-Component Support Strategies on HIV Virologic Suppression Rates during COVID-19: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2022 Mar 4. pii: 6542721. doi: 10.1093.
    >> Share

  628. BAI AD, Lo CKL, Komorowski AS, Suresh M, et al
    How generalizable are randomized controlled trials (RCTs) in Staphylococcus aureus bacteremia? A description of the mortality gap between RCTs and observational studies.
    Clin Infect Dis. 2022 Mar 4. pii: 6542216. doi: 10.1093.
    >> Share

  629. CHAN JF, Siu GK, Yuan S, Ip JD, et al
    Probable Animal-to-Human Transmission of SARS-CoV-2 Delta Variant AY.127 Causing a Pet Shop-Related COVID-19 Outbreak in Hong Kong.
    Clin Infect Dis. 2022 Mar 2. pii: 6541148. doi: 10.1093.
    >> Share

  630. SPEICH B, Chammartin F, Abela IA, Amico P, et al
    Antibody response in immunocompromised patients after the administration of SARS-CoV-2 vaccine BNT162b2 or mRNA-1273: A randomised controlled trial.
    Clin Infect Dis. 2022 Mar 2. pii: 6540899. doi: 10.1093.
    >> Share

  631. HOENIGL M, Abramovitz D, Flores Ortega RE, Martin NK, et al
    Sustained impact of the COVID-2019 pandemic on HCV treatment initiations in the United States.
    Clin Infect Dis. 2022 Mar 2. pii: 6540915. doi: 10.1093.
    >> Share

  632. FISMAN DN, Tuite AR
    Age-Specific Changes in Virulence Associated with SARS-CoV-2 Variants of Concern.
    Clin Infect Dis. 2022 Mar 2. pii: 6541156. doi: 10.1093.
    >> Share

  633. KOTILOGLU-KARAA E, Kele B, Kulasegaran-Shylini R, Broad CE, et al
    SARS-CoV-2 placental infection is associated with massive perivillous fibrin deposition at the maternal-fetal interface: a preliminary study".
    Clin Infect Dis. 2022 Mar 2. pii: 6540910. doi: 10.1093.
    >> Share

  634. GANDHI M
    Immunity Against the Omicron Variant from Vaccination, Recovery or Both.
    Clin Infect Dis. 2022 Mar 2. pii: 6540839. doi: 10.1093.
    >> Share

  635. SAUD Z, Ponsford M, Bentley K, Cole JM, et al
    Mechanically ventilated patients shed high titre live SARS-CoV2 for extended periods from both the upper and lower respiratory tract.
    Clin Infect Dis. 2022 Mar 1. pii: 6540532. doi: 10.1093.
    >> Share

    February 2022
  636. THURESSON S, Fraenkel CJ, Sasinovich S, Soldemyr J, et al
    Airborne SARS-CoV-2 in hospitals - effects of aerosol-generating procedures, HEPA-filtration units, patient viral load and physical distance.
    Clin Infect Dis. 2022 Feb 28. pii: 6539846. doi: 10.1093.
    >> Share

  637. SIVAPALASINGAM S, Lederer DJ, Bhore R, Hajizadeh N, et al
    Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
    Clin Infect Dis. 2022 Feb 26. pii: 6537638. doi: 10.1093.
    >> Share

  638. KATONA P, Kullar R, Zhang K
    Bringing Transmission of SARS-CoV-2 to the Surface: Is there a Role for Fomites?
    Clin Infect Dis. 2022 Feb 26. pii: 6537376. doi: 10.1093.
    >> Share

  639. COOPER DJ, Grigg MJ, Plewes K, Rajahram GS, et al
    The effect of regularly dosed acetaminophen versus no acetaminophen on renal function in Plasmodium knowlesi malaria (PACKNOW): a randomised controlled trial.
    Clin Infect Dis. 2022 Feb 18. pii: 6532035. doi: 10.1093.
    >> Share

  640. ERLANDSON KM, Fitch KV, McCallum SA, Ribaudo HJ, et al
    Geographical Differences in the Self-Reported Functional Impairment of People with HIV and Associations with Cardiometabolic Risk.
    Clin Infect Dis. 2022 Feb 15. pii: 6528571. doi: 10.1093.
    >> Share

  641. CONTOPOULOS-IOANNIDIS DG, Altamirano J, Maldonado Y
    Infectious Diseases-Related Hospitalizations During Oral Polio Vaccine(OPV) and non-OPV immunization periods: An Empirical Evaluation of all Hospital Discharges in California(1985-2010).
    Clin Infect Dis. 2022 Feb 9. pii: 6525447. doi: 10.1093.
    >> Share

  642. IMLAY H, Baum P, Brennan DC, Hanson KE, et al
    Consensus Definitions of BK Polyomavirus Nephropathy in Renal Transplant Recipients for Clinical Trials.
    Clin Infect Dis. 2022 Feb 1. pii: 6518218. doi: 10.1093.
    >> Share

    January 2022
  643. SPAULDING AC, Zawitz C
    Vaccination in Prisons and Jails: Corrections Needed in Future Plans.
    Clin Infect Dis. 2022 Jan 27. pii: 6515673. doi: 10.1093/cid/ciab1031.
    >> Share

  644. MUSSI-PINHATA MM, Ward S, Laimon L, Pelton SI, et al
    Effect of Maternal Vaccination of PCV-10, PPV-23 or Placebo on the Immunogenicity of PCV-10 in HIV-exposed Uninfected Infants: A Randomized Clinical Trial.
    Clin Infect Dis. 2022 Jan 17. pii: 6509061. doi: 10.1093.
    >> Share

  645. REDDY KP, Kruse GR, Lee S, Shuter J, et al
    Tobacco Use and Treatment of Tobacco Dependence Among People with HIV: A Practical Guide for Clinicians.
    Clin Infect Dis. 2022 Jan 3. pii: 6494528. doi: 10.1093/cid/ciab1069.
    >> Share

  646. JAKOBSEN A, Skov MT, Larsen L, Petersen PT, et al
    Herpes simplex virus 2 meningitis in adults: A prospective, nationwide, population-based cohort study.
    Clin Infect Dis. 2022 Jan 3. pii: 6494530. doi: 10.1093/cid/ciab1071.
    >> Share

    December 2021
  647. LOHR B, Niemann D, Verheyen J
    Bamlanivimab Treatment Leads to Rapid Selection of Immune Escape Variant Carrying the E484K Mutation in a B.1.1.7-Infected and Immunosuppressed Patient.
    Clin Infect Dis. 2021;73:2144-2145.
    >> Share

  648. JOSEPH NT, Satten GA, Williams RE, Haddad LB, et al
    The Effect of Antiretroviral Therapy for the Treatment of HIV-1 in Pregnancy on Gestational Weight Gain.
    Clin Infect Dis. 2021 Dec 3. pii: 6448917. doi: 10.1093.
    >> Share

    May 2021
  649. YADAV PD, Sapkal GN, Abraham P, Deshpande G, et al
    Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1.
    Clin Infect Dis. 2021 May 24. pii: 6283706. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016